1
|
Sunakawa Y, Kuboki Y, Watanabe J, Terazawa T, Kawakami H, Yokota M, Nakamura M, Kotaka M, Sugimoto N, Ojima H, Oki E, Kajiwara T, Yamamoto Y, Tsuji Y, Denda T, Tamura T, Ishihara S, Taniguchi H, Nakajima TE, Morita S, Shirao K, Takenaka N, Ozawa D, Yoshino T. Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer. Target Oncol 2024; 19:59-69. [PMID: 38194163 PMCID: PMC10830797 DOI: 10.1007/s11523-023-01027-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/02/2023] [Indexed: 01/10/2024]
Abstract
BACKGROUND The TRUSTY study evaluated the efficacy of second-line trifluridine/tipiracil (FTD/TPI) plus bevacizumab in metastatic colorectal cancer (mCRC). OBJECTIVE This exploratory biomarker analysis of TRUSTY investigated the relationship between baseline plasma concentrations of angiogenesis-related factors and cell-free DNA (cfDNA), and the efficacy of FTD/TPI plus bevacizumab in patients with mCRC. PATIENTS AND METHODS The disease control rate (DCR) and progression-free survival (PFS) were compared between baseline plasma samples of patients with high and low plasma concentrations (based on the median value) of angiogenesis-related factors. Correlations between cfDNA concentrations and PFS were assessed. RESULTS Baseline characteristics (n = 65) were as follows: male/female, 35/30; median age, 64 (range 25-84) years; and RAS status wild-type/mutant, 29/36. Patients in the hepatocyte growth factor (HGF)-low and interleukin (IL)-8-low groups had a significantly higher DCR (risk ratio [95% confidence intervals {CIs}]) than patients in the HGF-high (1.83 [1.12-2.98]) and IL-8-high (1.70 [1.02-2.82]) groups. PFS (hazard ratio {HR} [95% CI]) was significantly longer in patients in the HGF-low (0.33 [0.14-0.79]), IL-8-low (0.31 [0.14-0.70]), IL-6-low (0.19 [0.07-0.50]), osteopontin-low (0.39 [0.17-0.88]), thrombospondin-2-low (0.42 [0.18-0.98]), and tissue inhibitor of metalloproteinase-1-low (0.26 [0.10-0.67]) groups versus those having corresponding high plasma concentrations of these angiogenesis-related factors. No correlation was observed between cfDNA concentration and PFS. CONCLUSION Low baseline plasma concentrations of HGF and IL-8 may predict better DCR and PFS in patients with mCRC receiving FTD/TPI plus bevacizumab, however further studies are warranted. CLINICAL TRIAL REGISTRATION NUMBER jRCTs031180122.
Collapse
Affiliation(s)
- Yu Sunakawa
- Department of Clinical Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan.
| | - Yasutoshi Kuboki
- Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan
| | - Jun Watanabe
- Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan
| | - Tetsuji Terazawa
- Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan
| | - Hisato Kawakami
- Department of Medical Oncology, Kindai University Faculty of Medicine Hospital, Osaka-Sayama, Japan
| | - Mitsuru Yokota
- Department of General Surgery, Kurashiki Central Hospital, Kurashiki, Japan
| | - Masato Nakamura
- Aizawa Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan
| | | | - Naotoshi Sugimoto
- Department of Genetic Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Hitoshi Ojima
- Department of Gastroenterological Surgery, Gunma Prefectural Cancer Center, Ota, Japan
| | - Eiji Oki
- Department of Surgery and Science, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan
| | - Takeshi Kajiwara
- Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan
| | - Yoshiyuki Yamamoto
- Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
| | - Yasushi Tsuji
- Department of Medical Oncology, Tonan Hospital, Sapporo, Japan
| | - Tadamichi Denda
- Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan
| | - Takao Tamura
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Soichiro Ishihara
- Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan
| | - Hiroya Taniguchi
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
| | - Takako Eguchi Nakajima
- Department of Early Clinical Development, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Satoshi Morita
- Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | | | - Naruhito Takenaka
- Clinical Development and Medical Affairs Division, Taiho Pharmaceutical Co., Ltd, Tokyo, Japan
| | - Daisuke Ozawa
- Clinical Development and Medical Affairs Division, Taiho Pharmaceutical Co., Ltd, Tokyo, Japan
| | - Takayuki Yoshino
- Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| |
Collapse
|
2
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, de Nolfo GA, Ebisawa K, Ficklin AW, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, Okuno S, Ormes JF, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Zober WV. Direct Measurement of the Spectral Structure of Cosmic-Ray Electrons+Positrons in the TeV Region with CALET on the International Space Station. Phys Rev Lett 2023; 131:191001. [PMID: 38000434 DOI: 10.1103/physrevlett.131.191001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/02/2023] [Revised: 07/31/2023] [Accepted: 10/09/2023] [Indexed: 11/26/2023]
Abstract
Detailed measurements of the spectral structure of cosmic-ray electrons and positrons from 10.6 GeV to 7.5 TeV are presented from over 7 years of observations with the CALorimetric Electron Telescope (CALET) on the International Space Station. The instrument, consisting of a charge detector, an imaging calorimeter, and a total absorption calorimeter with a total depth of 30 radiation lengths at normal incidence and a fine shower imaging capability, is optimized to measure the all-electron spectrum well into the TeV region. Because of the excellent energy resolution (a few percent above 10 GeV) and the outstanding e/p separation (10^{5}), CALET provides optimal performance for a detailed search of structures in the energy spectrum. The analysis uses data up to the end of 2022, and the statistics of observed electron candidates has increased more than 3 times since the last publication in 2018. By adopting an updated boosted decision tree analysis, a sufficient proton rejection power up to 7.5 TeV is achieved, with a residual proton contamination less than 10%. The observed energy spectrum becomes gradually harder in the lower energy region from around 30 GeV, consistently with AMS-02, but from 300 to 600 GeV it is considerably softer than the spectra measured by DAMPE and Fermi-LAT. At high energies, the spectrum presents a sharp break around 1 TeV, with a spectral index change from -3.15 to -3.91, and a broken power law fitting the data in the energy range from 30 GeV to 4.8 TeV better than a single power law with 6.9 sigma significance, which is compatible with the DAMPE results. The break is consistent with the expected effects of radiation loss during the propagation from distant sources (except the highest energy bin). We have fitted the spectrum with a model consistent with the positron flux measured by AMS-02 below 1 TeV and interpreted the electron+positron spectrum with possible contributions from pulsars and nearby sources. Above 4.8 TeV, a possible contribution from known nearby supernova remnants, including Vela, is addressed by an event-by-event analysis providing a higher proton-rejection power than a purely statistical analysis.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - E Berti
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - C Checchia
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - A W Ficklin
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto, 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto, 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki, 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology (KOSEN), Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508, Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - H M Motz
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Graduate School of Science, Osaka Metropolitan University, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
- Nambu Yoichiro Institute for Theoretical and Experimental Physics, Osaka Metropolitan University, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - W V Zober
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| |
Collapse
|
3
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, de Nolfo GA, Ebisawa K, Ficklin AW, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, Okuno S, Ormes JF, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Zober WV. Erratum: Charge-Sign Dependent Cosmic-Ray Modulation Observed with the Calorimetric Electron Telescope on the International Space Station [Phys. Rev. Lett. 130, 211001 (2023)]. Phys Rev Lett 2023; 131:109902. [PMID: 37739390 DOI: 10.1103/physrevlett.131.109902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Indexed: 09/24/2023]
Abstract
This corrects the article DOI: 10.1103/PhysRevLett.130.211001.
Collapse
|
4
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, de Nolfo GA, Ebisawa K, Ficklin AW, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, Okuno S, Ormes JF, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Zober WV. Charge-Sign Dependent Cosmic-Ray Modulation Observed with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2023; 130:211001. [PMID: 37295105 DOI: 10.1103/physrevlett.130.211001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Revised: 03/16/2023] [Accepted: 04/13/2023] [Indexed: 06/12/2023]
Abstract
We present the observation of a charge-sign dependent solar modulation of galactic cosmic rays (GCRs) with the Calorimetric Electron Telescope onboard the International Space Station over 6 yr, corresponding to the positive polarity of the solar magnetic field. The observed variation of proton count rate is consistent with the neutron monitor count rate, validating our methods for determining the proton count rate. It is observed by the Calorimetric Electron Telescope that both GCR electron and proton count rates at the same average rigidity vary in anticorrelation with the tilt angle of the heliospheric current sheet, while the amplitude of the variation is significantly larger in the electron count rate than in the proton count rate. We show that this observed charge-sign dependence is reproduced by a numerical "drift model" of the GCR transport in the heliosphere. This is a clear signature of the drift effect on the long-term solar modulation observed with a single detector.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - E Berti
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, Saint Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, Saint Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - C Checchia
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - A W Ficklin
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, Saint Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, Saint Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology (KOSEN), Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508, Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - P Papini
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, Saint Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Graduate School of Science, Osaka Metropolitan University, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
- Nambu Yoichiro Institute for Theoretical and Experimental Physics, Osaka Metropolitan University, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Firenze, Via Sansone, 1 - 50019, Sesto Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - W V Zober
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, Saint Louis, Missouri 63130-4899, USA
| |
Collapse
|
5
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, de Nolfo GA, Ebisawa K, Ficklin AW, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, Okuno S, Ormes JF, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Zober WV. Direct Measurement of the Cosmic-Ray Helium Spectrum from 40 GeV to 250 TeV with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2023; 130:171002. [PMID: 37172251 DOI: 10.1103/physrevlett.130.171002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Accepted: 04/03/2023] [Indexed: 05/14/2023]
Abstract
We present the results of a direct measurement of the cosmic-ray helium spectrum with the CALET instrument in operation on the International Space Station since 2015. The observation period covered by this analysis spans from October 13, 2015, to April 30, 2022 (2392 days). The very wide dynamic range of CALET allowed for the collection of helium data over a large energy interval, from ∼40 GeV to ∼250 TeV, for the first time with a single instrument in low Earth orbit. The measured spectrum shows evidence of a deviation of the flux from a single power law by more than 8σ with a progressive spectral hardening from a few hundred GeV to a few tens of TeV. This result is consistent with the data reported by space instruments including PAMELA, AMS-02, and DAMPE and balloon instruments including CREAM. At higher energy we report the onset of a softening of the helium spectrum around 30 TeV (total kinetic energy). Though affected by large uncertainties in the highest energy bins, the observation of a flux reduction turns out to be consistent with the most recent results of DAMPE. A double broken power law is found to fit simultaneously both spectral features: the hardening (at lower energy) and the softening (at higher energy). A measurement of the proton to helium flux ratio in the energy range from 60 GeV/n to about 60 TeV/n is also presented, using the CALET proton flux recently updated with higher statistics.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - E Berti
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - C Checchia
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - A W Ficklin
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto, 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto, 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki, 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology (KOSEN), Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508, Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - P Papini
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019, Sesto Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Graduate School of Science, Osaka Metropolitan University, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
- Nambu Yoichiro Institute for Theoretical and Experimental Physics, Osaka Metropolitan University, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Firenze, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - W V Zober
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| |
Collapse
|
6
|
Aoki M, Kadowaki S, Takahashi N, Suzuki T, Oshima K, Ando T, Yamamoto Y, Kawakami K, Kito Y, Matsumoto T, Shimozaki K, Miyazaki Y, Yamaguchi T, Nagase M, Tamura T, Amanuma Y, Esaki T, Miura Y, Akiyoshi K, Baba E, Makiyama A, Negoro Y, Nakashima K, Sugimoto N, Nagashima K, Shoji H, Boku N. Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan. Gastric Cancer 2023; 26:132-144. [PMID: 36316527 PMCID: PMC9813080 DOI: 10.1007/s10120-022-01349-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Accepted: 10/18/2022] [Indexed: 11/05/2022]
Abstract
BACKGROUND Accelerated tumor growth during immunotherapy in pre-existing measurable lesions, hyperprogressive disease (HPD), has been reported. However, progression of non-measurable lesions and new lesions are frequently observed in patients with advanced gastric cancer (AGC). METHODS This retrospective study involved AGC patients at 24 Japanese institutions who had measurable lesions and received nivolumab after ≥ 2 lines of chemotherapy. HPD was defined as a ≥ two-fold increase in the tumor growth rate of measurable lesions. The pattern of disease progression was classified according to new lesions in different organs and ascites appeared/increase of ascites. RESULTS Of 245 patients, 147 (60.0%) showed progressive disease (PD) as the best response and 41 (16.7%) showed HPD during nivolumab monotherapy. There was no significant difference in overall survival (OS) between patients with HPD and those with PD other than HPD (median OS 5.0 vs 4.8 months; hazard ratio [HR] 1.0, 95% confidence interval [CI] 0.6-1.5; p = 1.0). Fifty-three patients developed new lesions in different organs and 58 had appearance/increase of ascites; these patients showed shorter OS than those without each of these features (median OS 3.3 vs 7.1 months, HR 1.8, 95% CI 1.2-2.7, p = 0.0031 for new lesions, and 3.0 vs 7.8 months, HR 2.6, 95% CI 1.8-3.8, p < 0.0001 for ascites). Thirty-one patients who had both features showed the worst prognosis (median OS 2.6 months). CONCLUSIONS New lesions in different organs and appearance/increase of ascites, rather than the original definition of HPD, are the patterns of disease progression associated with poor prognosis in AGC patients receiving nivolumab whose best response was PD.
Collapse
Affiliation(s)
- Masahiko Aoki
- Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
- Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - Shigenori Kadowaki
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan
| | - Naoki Takahashi
- Division of Gastroenterology, Saitama Cancer Center, Saitama, Japan
| | - Takeshi Suzuki
- Department of Gastroenterology, The Cancer Institute Hospital, Tokyo, Japan
| | - Kotoe Oshima
- Department of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
| | - Takayuki Ando
- Third Department of Internal Medicine, University of Toyama, Toyama, Japan
| | - Yoshiyuki Yamamoto
- Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
| | - Kentaro Kawakami
- Department of Medical Oncology, Keiyukai Sapporo Hospital, Hokkaido, Japan
| | - Yosuke Kito
- Department of Medical Oncology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan
| | - Toshihiko Matsumoto
- Department of Internalmedicine, Himeji Red Cross Hospital, Hyogo, Japan
- Cancer Treatment Center, Kansai Medical University Hospital, Osaka, Japan
| | - Keitaro Shimozaki
- Division of Gastroenterology and Hepatology, Depart of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
| | | | - Toshifumi Yamaguchi
- Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Osaka, Japan
| | - Michitaka Nagase
- Department of Medical Oncology, Saku Central Hospital Advanced Care Center, Nagano, Japan
| | - Takao Tamura
- Department of Medical Oncology, Kindai University Nara Hospital, Nara, Japan
| | - Yusuke Amanuma
- Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan
| | - Taito Esaki
- Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
| | - Yuji Miura
- Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan
| | - Kohei Akiyoshi
- Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan
| | - Eishi Baba
- Department of Oncology and Social Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
| | - Akitaka Makiyama
- Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
- Cancer Center, Gifu University Hospital, Gifu, Japan
| | - Yuji Negoro
- Division of Gastroenterological Medicine, Kochi Health Sciences Center, Kochi, Japan
| | - Koji Nakashima
- Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki, Japan
| | - Naotoshi Sugimoto
- Department of Genetic Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Kengo Nagashima
- Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan
| | - Hirokazu Shoji
- Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - Narikazu Boku
- Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Oncology and General Medicine, IMSUT Hospital, Institute of Medical Science, University of Tokyo, 4-6-1 Shiroganedai, Minato-Ku, Tokyo, 108-8639, Japan.
| |
Collapse
|
7
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, de Nolfo GA, Ebisawa K, Ficklin AW, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, Okuno S, Ormes JF, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Zober WV. Cosmic-Ray Boron Flux Measured from 8.4 GeV/n to 3.8 TeV/n with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2022; 129:251103. [PMID: 36608255 DOI: 10.1103/physrevlett.129.251103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Revised: 11/07/2022] [Accepted: 11/22/2022] [Indexed: 06/17/2023]
Abstract
We present the measurement of the energy dependence of the boron flux in cosmic rays and its ratio to the carbon flux in an energy interval from 8.4 GeV/n to 3.8 TeV/n based on the data collected by the Calorimetric Electron Telescope (CALET) during ∼6.4 yr of operation on the International Space Station. An update of the energy spectrum of carbon is also presented with an increase in statistics over our previous measurement. The observed boron flux shows a spectral hardening at the same transition energy E_{0}∼200 GeV/n of the C spectrum, though B and C fluxes have different energy dependences. The spectral index of the B spectrum is found to be γ=-3.047±0.024 in the interval 25<E<200 GeV/n. The B spectrum hardens by Δγ_{B}=0.25±0.12, while the best fit value for the spectral variation of C is Δγ_{C}=0.19±0.03. The B/C flux ratio is compatible with a hardening of 0.09±0.05, though a single power-law energy dependence cannot be ruled out given the current statistical uncertainties. A break in the B/C ratio energy dependence would support the recent AMS-02 observations that secondary cosmic rays exhibit a stronger hardening than primary ones. We also perform a fit to the B/C ratio with a leaky-box model of the cosmic-ray propagation in the Galaxy in order to probe a possible residual value λ_{0} of the mean escape path length λ at high energy. We find that our B/C data are compatible with a nonzero value of λ_{0}, which can be interpreted as the column density of matter that cosmic rays cross within the acceleration region.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - E Berti
- Department of Physics Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - C Checchia
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - A W Ficklin
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwakecho, Sakyo, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwakecho, Sakyo, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology, Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508 Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- Department of Physics Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - P Spillantini
- Department of Physics Department of Physics, University of Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Graduate School of Science, Osaka Metropolitan University, 3-3-138, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
- Nambu Yoichiro Institute for Theoretical and Experimental Physics, Osaka Metropolitan University, 3-3-138, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1-50019, Sesto Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - W V Zober
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| |
Collapse
|
8
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Ebisawa K, Ficklin AW, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Zober WV. Observation of Spectral Structures in the Flux of Cosmic-Ray Protons from 50 GeV to 60 TeV with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2022; 129:101102. [PMID: 36112450 DOI: 10.1103/physrevlett.129.101102] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Revised: 07/19/2022] [Accepted: 08/03/2022] [Indexed: 06/15/2023]
Abstract
A precise measurement of the cosmic-ray proton spectrum with the Calorimetric Electron Telescope (CALET) is presented in the energy interval from 50 GeV to 60 TeV, and the observation of a softening of the spectrum above 10 TeV is reported. The analysis is based on the data collected during ∼6.2 years of smooth operations aboard the International Space Station and covers a broader energy range with respect to the previous proton flux measurement by CALET, with an increase of the available statistics by a factor of ∼2.2. Above a few hundred GeV we confirm our previous observation of a progressive spectral hardening with a higher significance (more than 20 sigma). In the multi-TeV region we observe a second spectral feature with a softening around 10 TeV and a spectral index change from -2.6 to -2.9 consistently, within the errors, with the shape of the spectrum reported by DAMPE. We apply a simultaneous fit of the proton differential spectrum which well reproduces the gradual change of the spectral index encompassing the lower energy power-law regime and the two spectral features observed at higher energies.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - E Berti
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto Fiorentino, Italy
| | - C Checchia
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - A W Ficklin
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology (KOSEN), Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508, Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto Fiorentino, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Graduate School of Science, Osaka Metropolitan University, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
- Nambu Yoichiro Institute for Theoretical and Experimental Physics, Osaka Metropolitan University, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - W V Zober
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| |
Collapse
|
9
|
Hakozaki T, Nolin-Lapalme A, Kogawa M, Okuma Y, Nakamura S, Tamura T, Hosomi Y, Takeyama H, Richard C, Hosokawa M, Routy B. 1076P Cancer cachexia associated with gut microbiota and clinical outcomes of patients with non-small cell lung cancer amenable to immunotherapy. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
10
|
Taniguchi H, Kuboki Y, Watanabe J, Terazawa T, Kawakami H, Yokota M, Nakamura M, Kotaka M, Sugimoto N, Ojima H, Oki E, Kajiwara T, Moriwaki T, Takayama T, Denda T, Tamura T, Sunakawa Y, Ishihara S, Nakajima T, Morita S, Shirao K, Yoshino T. SO-19 Biomarker analysis using plasma angiogenesis factors in the TRUSTY study: A randomized phase 2/3 study of trifluridine/tipiracil plus bevacizumab as second-line treatment for metastatic colorectal cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
11
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Ebisawa K, Ficklin AW, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ospina N, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K, Zober WV. Direct Measurement of the Nickel Spectrum in Cosmic Rays in the Energy Range from 8.8 GeV/n to 240 GeV/n with CALET on the International Space Station. Phys Rev Lett 2022; 128:131103. [PMID: 35426700 DOI: 10.1103/physrevlett.128.131103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/27/2021] [Revised: 02/03/2022] [Accepted: 02/28/2022] [Indexed: 06/14/2023]
Abstract
The relative abundance of cosmic ray nickel nuclei with respect to iron is by far larger than for all other transiron elements; therefore it provides a favorable opportunity for a low background measurement of its spectrum. Since nickel, as well as iron, is one of the most stable nuclei, the nickel energy spectrum and its relative abundance with respect to iron provide important information to estimate the abundances at the cosmic ray source and to model the Galactic propagation of heavy nuclei. However, only a few direct measurements of cosmic-ray nickel at energy larger than ∼3 GeV/n are available at present in the literature, and they are affected by strong limitations in both energy reach and statistics. In this Letter, we present a measurement of the differential energy spectrum of nickel in the energy range from 8.8 to 240 GeV/n, carried out with unprecedented precision by the Calorimetric Electron Telescope (CALET) in operation on the International Space Station since 2015. The CALET instrument can identify individual nuclear species via a measurement of their electric charge with a dynamic range extending far beyond iron (up to atomic number Z=40). The particle's energy is measured by a homogeneous calorimeter (1.2 proton interaction lengths, 27 radiation lengths) preceded by a thin imaging section (3 radiation lengths) providing tracking and energy sampling. This Letter follows our previous measurement of the iron spectrum [1O. Adriani et al. (CALET Collaboration), Phys. Rev. Lett. 126, 241101 (2021).PRLTAO0031-900710.1103/PhysRevLett.126.241101], and it extends our investigation on the energy dependence of the spectral index of heavy elements. It reports the analysis of nickel data collected from November 2015 to May 2021 and a detailed assessment of the systematic uncertainties. In the region from 20 to 240 GeV/n our present data are compatible within the errors with a single power law with spectral index -2.51±0.07.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - E Berti
- Department of Physics, University of Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto Fiorentino, Italy
| | - C Checchia
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - A W Ficklin
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
- Department of Astronomy, Graduate School of Science, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology, Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508, Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - N Ospina
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- Department of Physics, University of Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto Fiorentino, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3 - 56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Division of Mathematics and Physics, Graduate School of Science, Osaka City University, 3-3-138 Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
- Nambu Yoichiro Institute of Theoretical and Experimental Physics, Osaka City University, 3-3-138 Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1 - 50019 Sesto Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - W V Zober
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| |
Collapse
|
12
|
Kang YK, Morita S, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Chen LT, Boku N. Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study. Gastric Cancer 2022; 25:207-217. [PMID: 34480657 PMCID: PMC8732926 DOI: 10.1007/s10120-021-01230-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Accepted: 08/04/2021] [Indexed: 02/07/2023]
Abstract
BACKGROUND The phase 3 ATTRACTION-2 study demonstrated that nivolumab monotherapy was superior to placebo for patients with pretreated advanced gastric or gastroesophageal junction cancer, but early progression of tumors in some patients was of concern. METHODS This post hoc analysis statistically explored the baseline characteristics of the ATTRACTION-2 patients and extracted a single-factor and double-factor combinations associated with early disease progression or early death. In the extracted patient subgroups, the 3-year restricted mean survival times of progression-free survival and overall survival were compared between the nivolumab and placebo arms. RESULTS Two single factors (age and peritoneal metastasis) were extracted as independent predictors of early progression, but none of them, as a single factor, stratified patients into two subgroups with significant differences in restricted mean survival time. In contrast, two double-factor combinations (serum sodium level and white blood cell count; serum sodium level and neutrophil-lymphocyte ratio) stratifying patients into two subgroups with significant differences in the restricted mean survival time were extracted. Additional exploratory analysis of a triple-factor combination showed that patients aged < 60 years with peritoneal metastasis and low serum sodium levels (approximately 7% of all patients) might receive less benefit from nivolumab, and patients aged ≥ 60 years with no peritoneal metastasis and normal serum sodium levels might receive higher benefit. CONCLUSIONS A combination of age, peritoneal metastasis, and serum sodium level might predict benefit from nivolumab as salvage therapy in advanced gastric or gastroesophageal junction cancer patients, especially less benefit for patients having all three risk factors.
Collapse
Affiliation(s)
- Yoon-Koo Kang
- grid.267370.70000 0004 0533 4667Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Satoshi Morita
- grid.258799.80000 0004 0372 2033Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan
| | - Taroh Satoh
- grid.136593.b0000 0004 0373 3971Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan
| | - Min-Hee Ryu
- grid.267370.70000 0004 0533 4667Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Yee Chao
- grid.278247.c0000 0004 0604 5314Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
| | - Ken Kato
- grid.272242.30000 0001 2168 5385Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - Hyun Cheol Chung
- grid.15444.300000 0004 0470 5454Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Jen-Shi Chen
- grid.145695.a0000 0004 1798 0922Division of Hematology and Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
| | - Kei Muro
- grid.410800.d0000 0001 0722 8444Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
| | - Won Ki Kang
- grid.264381.a0000 0001 2181 989XDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Kun-Huei Yeh
- grid.412094.a0000 0004 0572 7815Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
| | - Takaki Yoshikawa
- grid.414944.80000 0004 0629 2905Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan ,grid.272242.30000 0001 2168 5385Present Address: Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
| | - Sang Cheul Oh
- grid.222754.40000 0001 0840 2678Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, South Korea
| | - Li-Yuan Bai
- grid.254145.30000 0001 0083 6092Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan
| | - Takao Tamura
- grid.258622.90000 0004 1936 9967Department of Medical Oncology, Faculty of Medicine, Kindai University, Osakasayama, Japan ,grid.258622.90000 0004 1936 9967Present Address: Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Keun-Wook Lee
- grid.31501.360000 0004 0470 5905Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Yasuo Hamamoto
- grid.26091.3c0000 0004 1936 9959Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan
| | - Jong Gwang Kim
- grid.258803.40000 0001 0661 1556Kyungpook National University School of Medicine, Daegu, South Korea
| | - Keisho Chin
- grid.410807.a0000 0001 0037 4131Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Do-Youn Oh
- grid.31501.360000 0004 0470 5905Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, South Korea
| | - Keiko Minashi
- grid.418490.00000 0004 1764 921XDepartment of Clinical Trial Promotion, Chiba Cancer Center, Chiba, Japan
| | - Jae Yong Cho
- grid.15444.300000 0004 0470 5454Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - Masahiro Tsuda
- grid.417755.50000 0004 0378 375XDepartment of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan
| | - Hiroki Sameshima
- grid.459873.40000 0004 0376 2510Medical Affairs, Ono Pharmaceutical, Co. Ltd., Osaka, Japan
| | - Li-Tzong Chen
- grid.59784.370000000406229172National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan ,grid.412019.f0000 0000 9476 5696Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - Narikazu Boku
- grid.272242.30000 0001 2168 5385Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
| |
Collapse
|
13
|
Kimura T, Takahama T, Wakasa T, Adachi S, Akashi Y, Tamura T, Yane K. Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma. Mol Clin Oncol 2021; 16:2. [PMID: 34824842 DOI: 10.3892/mco.2021.2435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 08/23/2021] [Indexed: 11/05/2022] Open
Abstract
Immune checkpoint inhibitors (ICIs) have markedly changed the treatment landscape for melanoma; however, their efficacy and applications are currently limited and medical requirements remain unmet. The present case study reports on a 85-year-old female patient who visited our outpatient clinic with a 1-month history of a buccal mucosa mass and was diagnosed with locally advanced mucosal melanoma of the head and neck. The patient's tumor progressed right after the administration of nivolumab, compromising oral intake. Palliative debulking surgery was performed. Subsequently, the other part of the melanoma on the hard palate slightly decreased in size without forming new lesions for more than one year after surgery. The present case exemplifies that tumor volume reduction surgery may increase the response to ICI and may prolong the duration of response. This combination therapy may be more effective in patients whose tumors increase in size after administration of ICIs or whose tumor is already large at the beginning of treatment. The combination of ICIs and debulking surgery may become an important treatment option in the future for locally advanced mucosal melanoma.
Collapse
Affiliation(s)
- Takahiro Kimura
- Department of Otorhinolaryngology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan
| | - Takayuki Takahama
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan
| | - Tomoko Wakasa
- Department of Diagnostic Pathology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan
| | - Shiori Adachi
- Department of Otorhinolaryngology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan
| | - Yusaku Akashi
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan
| | - Takao Tamura
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan
| | - Katsunari Yane
- Department of Otorhinolaryngology, Kindai University Nara Hospital, Ikoma, Nara 630-0293, Japan
| |
Collapse
|
14
|
Hirokane E, Takamizawa T, Tamura T, Shibasaki S, Tsujimoto A, Barkmeier WW, Latta MA, Miyazaki M. Handling and Mechanical Properties of Low-viscosity Bulk-fill Resin Composites. Oper Dent 2021; 46:E185-E198. [PMID: 35486512 DOI: 10.2341/20-253-l] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/23/2021] [Indexed: 11/23/2022]
Abstract
This study aimed to evaluate the filler contents (FCs), flexural properties, depth of cure (DOC), wear resistance, and handling properties of different low-viscosity bulk-fill resin composites (LVBRCs) and to determine the correlations between the tested parameters. Six LVBRCs, Beautifil-Bulk (BBF), Bulk Base Hard (BBH), Bulk Base Medium (BBM), Filtek Bulk-Fill Flowable Restorative (FBF), G-ænial Bulk Injectable (GBI), and SDR flow+ Bulk-Fill Flowable (SDR) were used. The DOC and flexural property tests were conducted according to the ISO 4049 specifications. The flexural strength, elastic modulus, and resilience were determined in 12 specimens that were obtained from each of the 6 materials. Sliding-impact-wear testing was conducted by evaluating the wear facets of the specimens using a noncontact profilometer and by confocal laser scanning microscopy. The handling properties of the LVBRC was assessed via extrusion force and thread formation measurements. The DOC for the majority of the LVBRCs was approximately 4 mm. Although the FCs and mechanical properties were material dependent, some LVBRCs exhibited excellent flexural properties and wear resistance. The LVBRCs demonstrated a wide range of extrusion force and thread formation. Regarding the correlations between the tested parameters, extremely strong negative and positive correlations were observed for the DOC versus extrusion force, flexural strength versus elastic modulus, maximum depth versus volume loss, and maximum depth versus thread formation. In addition, strong correlations between FCs and DOC, resilience, wear resistance, and extrusion force were observed.
Collapse
Affiliation(s)
- E Hirokane
- Eizo Hirokane, DDS, Department of Operative Dentistry, Nihon University Graduate School of Dentistry, Tokyo, Japan
| | - T Takamizawa
- *Toshiki Takamizawa, DDS, PhD, Department of Operative Dentistry, Nihon University School of Dentistry, Tokyo, Japan
| | - T Tamura
- Tomohiko Tamura, DDS, Department of Operative Dentistry, Nihon University Graduate School of Dentistry, Tokyo, Japan
| | - S Shibasaki
- Sho Shibasaki, DDS, PhD, Department of Operative Dentistry, Nihon University School of Dentistry, Tokyo, Japan
| | - A Tsujimoto
- Akimasa Tsujimoto, DDS, PhD, Department of Operative Dentistry, University of Iowa College of Dentistry, Iowa City, IA, USA
| | - W W Barkmeier
- Wayne W. Barkmeier, DDS, MS, Department of General Dentistry, Creighton University School of Dentistry, Omaha, NE, USA
| | - M A Latta
- Mark A. Latta, DMD, MS, Department of General Dentistry, Creighton University School of Dentistry, Omaha, NE, USA
| | - M Miyazaki
- Masashi Miyazaki, DDS, PhD, Department of Operative Dentistry, Nihon University School of Dentistry, Tokyo, Japan
| |
Collapse
|
15
|
Kawase T, Imamura H, Goto M, Kimura Y, Ueda S, Matsuyama J, Nishikawa K, Sugimoto N, Fujita J, Tamura T, Fukushima N, Kawakami H, Sakai D, Kurokawa Y, Shimokawa T, Satoh T. Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701. Int J Clin Oncol 2021; 26:1871-1880. [PMID: 34453640 DOI: 10.1007/s10147-021-01984-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Accepted: 06/27/2021] [Indexed: 11/26/2022]
Abstract
BACKGROUND To compare irinotecan-alone, paclitaxel-alone, and each combination chemotherapy with S-1 in patients with advanced gastric cancer (AGC) that is refractory to S-1 or S-1 plus cisplatin (SP). METHODS Patients with AGC after first-line chemotherapy with S-1 or SP, or patients during adjuvant chemotherapy or within 26 weeks after adjuvant chemotherapy completion with S-1 with confirmed disease progression were eligible. Patients were randomly divided into four groups based on treatment: irinotecan-alone (irinotecan; 150 mg/m2, day 1, q14 days), paclitaxel-alone (paclitaxel; 80 mg/m2, days 1, 8, 15, q28 days), S-1 plus irinotecan (irinotecan; 80 mg/m2, days 1, 15, S-1; 80 mg/m2, days 1-21, q35 days), and S-1 plus paclitaxel (paclitaxel; 50 mg/m2, day1, 8, S-1; 80 mg/m2, days 1-14, q21 days). The primary endpoint was overall survival (OS) and secondary endpoints were progression-free survival (PFS), response rate, and safety. RESULTS From July 2008 to March 2012, 127 patients were enrolled. No difference in median OS was observed in the irinotecan vs. paclitaxel groups or in the monotherapy groups vs. the S-1 combination therapy groups. Median PFS was longer in the paclitaxel group compared with the irinotecan group (4.1 vs. 3.6 months, p = 0.035), although no difference was observed when comparing monotherapy vs. S-1 combination. The most common grade 3 to 4 hematological adverse events were neutropenia with no difference in incidence rate across the treatment groups. CONCLUSIONS There was no difference in OS between irinotecan and paclitaxel no in OS prolongation of S-1 combination therapy in second-line chemotherapy.
Collapse
Affiliation(s)
- Tomono Kawase
- Department of Surgery, Toyonaka Municipal Hospital, 4-14-1 Shibahara-cho, Toyonaka, Japan
| | - Hiroshi Imamura
- Department of Surgery, Toyonaka Municipal Hospital, 4-14-1 Shibahara-cho, Toyonaka, Japan.
| | - Masahiro Goto
- Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan
| | - Yutaka Kimura
- Department of Surgery, Faculty of Medicine, Kinki University, Sayama, Japan
| | - Shugo Ueda
- Department of Gastroenterological Surgery, Kitano Hospital, Osaka, Japan
| | - Jin Matsuyama
- Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan
| | | | - Naotoshi Sugimoto
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Junya Fujita
- Department of Surgery, Sakai City Medical Center, Sakai, Japan
| | - Takao Tamura
- Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan
| | - Norimasa Fukushima
- Department of Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan
| | - Hisato Kawakami
- Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan
| | - Daisuke Sakai
- Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan
| | - Yukinori Kurokawa
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| | - Toshio Shimokawa
- Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan
| | - Taroh Satoh
- Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan
| |
Collapse
|
16
|
Takahama T, Ichimura N, Okabe T, Akashi Y, Tamura T, Shimoyoshi M, Kameda K, Wakasa T, Ohta Y, Yamada H, Yukawa M. MO28-4 Multi-disciplinary collaboration on gene panel testing and review of factors in cases of unsuitable for gene profiling. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
17
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Ebisawa K, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Link J, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ospina N, Ozawa S, Pacini L, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Spillantini P, Stolzi F, Sugita S, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K. Measurement of the Iron Spectrum in Cosmic Rays from 10 GeV/n to 2.0 TeV/n with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2021; 126:241101. [PMID: 34213922 DOI: 10.1103/physrevlett.126.241101] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/15/2021] [Revised: 02/24/2021] [Accepted: 04/12/2021] [Indexed: 06/13/2023]
Abstract
The Calorimetric Electron Telescope (CALET), in operation on the International Space Station since 2015, collected a large sample of cosmic-ray iron over a wide energy interval. In this Letter a measurement of the iron spectrum is presented in the range of kinetic energy per nucleon from 10 GeV/n to 2.0 TeV/n allowing the inclusion of iron in the list of elements studied with unprecedented precision by space-borne instruments. The measurement is based on observations carried out from January 2016 to May 2020. The CALET instrument can identify individual nuclear species via a measurement of their electric charge with a dynamic range extending far beyond iron (up to atomic number Z=40). The energy is measured by a homogeneous calorimeter with a total equivalent thickness of 1.2 proton interaction lengths preceded by a thin (3 radiation lengths) imaging section providing tracking and energy sampling. The analysis of the data and the detailed assessment of systematic uncertainties are described and results are compared with the findings of previous experiments. The observed differential spectrum is consistent within the errors with previous experiments. In the region from 50 GeV/n to 2 TeV/n our present data are compatible with a single power law with spectral index -2.60±0.03.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - E Berti
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - C Checchia
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwakecho, Sakyo, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Hakubi Center, Kyoto University, Yoshida Honmachi, Sakyo-ku, Kyoto 606-8501, Japan
- Department of Astronomy, Graduate School of Science, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J Link
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology, Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508, Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - N Ospina
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3, 56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Division of Mathematics and Physics, Graduate School of Science, Osaka City University, 3-3-138 Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1, 50019 Sesto, Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| |
Collapse
|
18
|
Nakajima H, Fukuoka S, Masuishi T, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Negoro Y, Komoda M, Makiyama A, Denda T, Hatachi Y, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Ando K, Yuki S, Okuyama H, Kusaba H, Sakai D, Okamoto K, Tamura T, Yamashita K, Gosho M, Moriwaki T. Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment. Front Oncol 2021; 11:688709. [PMID: 34211856 PMCID: PMC8239287 DOI: 10.3389/fonc.2021.688709] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Accepted: 04/30/2021] [Indexed: 12/27/2022] Open
Abstract
Background Primary tumor location (PTL) is an important prognostic and predictive factor in the first-line treatment of metastatic colorectal cancer (mCRC). Although regorafenib (REG) and trifluridine/tipiracil (FTD/TPI) have been introduced recently, the clinical impact of PTL in these treatments is not well understood. Materials and Methods We retrospectively evaluated patients with mCRC who were registered in a multicenter observational study (the REGOTAS study). The main inclusion criteria were Eastern Cooperative Oncology Group performance status (ECOG PS) of 0-2, refractory or intolerant to fluoropyrimidines, oxaliplatin, irinotecan, angiogenesis inhibitors, anti-epidermal growth factor receptor therapy (if RAS wild-type), and no prior use of REG and FTD/TPI. The impact of PTL on overall survival (OS) was evaluated using Cox proportional hazard models based on baseline characteristics. Results A total of 550 patients (223 patients in the REG group and 327 patients in the FTD/TPI group) were included in this study, with 122 patients with right-sided tumors and 428 patients with left-sided tumors. Although the right-sided patients had significantly shorter OS compared with the left-sided patients by univariate analysis (p = 0.041), a multivariate analysis revealed that PTL was not an independent prognostic factor (hazard ratio, 0.95; p = 0.64). In a subgroup analysis, the OS was comparable between the REG and FTD/TPI groups regardless of PTL (p for interactions = 0.60). Conclusions In the present study, PTL is not a prognostic and predictive factor in patients with mCRC under later-line REG or FTD/TPI therapy.
Collapse
Affiliation(s)
- Hiromichi Nakajima
- Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan
| | - Shota Fukuoka
- Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan
| | - Toshiki Masuishi
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan
| | - Atsuo Takashima
- Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
| | - Yosuke Kumekawa
- Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan
| | - Takeshi Kajiwara
- Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan
| | - Kentaro Yamazaki
- Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
| | - Yuji Negoro
- Clinical Oncology Division, Kochi Health Sciences Center, Kochi, Japan
| | - Masato Komoda
- Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
| | - Akitaka Makiyama
- Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.,Cancer Center, Gifu University Hospital, Gifu, Japan
| | - Tadamichi Denda
- Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan
| | - Yukimasa Hatachi
- Department of Clinical Oncology, Kansai Rosai Hospital, Hyogo, Japan
| | - Takeshi Suto
- Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan
| | - Naotoshi Sugimoto
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Masanobu Enomoto
- Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan
| | - Toshiaki Ishikawa
- Department of Specialized Surgeries, Graduate School of Medicine and Dentistry, Tokyo Medical and Dental University, Tokyo, Japan
| | - Tomomi Kashiwada
- Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - Koji Ando
- Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Satoshi Yuki
- Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Hokkaido, Japan
| | - Hiroyuki Okuyama
- Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan
| | - Hitoshi Kusaba
- Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Daisuke Sakai
- Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Koichi Okamoto
- Department of Surgery, National Defense Medical College, Saitama, Japan
| | - Takao Tamura
- Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan
| | - Kimihiro Yamashita
- Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Hyogo, Japan
| | - Masahiko Gosho
- Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
| | - Toshikazu Moriwaki
- Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan
| |
Collapse
|
19
|
Sugawara S, Lee JS, Kang JH, Kim HR, Inui N, Hida T, Lee KH, Yoshida T, Tanaka H, Yang CT, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Namba Y, Sumiyoshi N, Nakagawa K. Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer. Ann Oncol 2021; 32:1137-1147. [PMID: 34139272 DOI: 10.1016/j.annonc.2021.06.004] [Citation(s) in RCA: 83] [Impact Index Per Article: 27.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2021] [Revised: 05/26/2021] [Accepted: 06/10/2021] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND This international, randomized, double-blind phase III study (ONO-4538-52/TASUKI-52) evaluated nivolumab with bevacizumab and cytotoxic chemotherapy as first-line treatment for nonsquamous non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS Between June 2017 and July 2019, this study enrolled treatment-naïve patients with stage IIIB/IV or recurrent nonsquamous NSCLC without sensitizing EGFR, ALK, or ROS1 alterations. They were randomly assigned in a 1 : 1 ratio to receive nivolumab or placebo in combination with carboplatin, paclitaxel, and bevacizumab every 3 weeks for up to six cycles, followed by nivolumab/placebo with bevacizumab until progressive disease or unacceptable toxicity. The primary endpoint was progression-free survival (PFS) assessed by an independent radiology review committee (IRRC). RESULTS Overall, 550 patients from Japan, Korea, and Taiwan were randomized; of these patients, 273 and 275 received the nivolumab and placebo combinations, respectively. In the present preplanned interim analysis with a median follow up of 13.7 months, the IRRC-assessed median PFS was significantly longer in the nivolumab arm than in the placebo arm (12.1 versus 8.1 months; hazard ratio 0.56; 96.4% confidence interval 0.43-0.71; P < 0.0001). The PFS benefit was observed across all patients with any programmed death-ligand 1 (PD-L1) expression levels including PD-L1-negative patients. The IRRC-assessed objective response rates were 61.5% and 50.5% in the nivolumab and placebo arms, respectively. The incidence of treatment-related adverse events of grade 3 or 4 was comparable between the two arms; treatment-related adverse events leading to death were observed in five and four patients in the nivolumab and placebo arms, respectively. CONCLUSION The TASUKI-52 regimen should be considered a viable new treatment strategy for treatment-naïve patients with advanced nonsquamous NSCLC.
Collapse
Affiliation(s)
- S Sugawara
- Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan
| | - J-S Lee
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea
| | - J-H Kang
- Department of Medical Oncology, The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea
| | - H R Kim
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
| | - N Inui
- Department of Pulmonary Medicine, Hamamatsu University Hospital, Shizuoka, Japan
| | - T Hida
- Department of Thoracic Oncology, Aichi Cancer Center, Aichi, Japan
| | - K H Lee
- Department of Internal Medicine, Chungbuk National University Hospital, Chungcheongbuk-do, Korea
| | - T Yoshida
- Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - H Tanaka
- Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan
| | - C-T Yang
- Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
| | - M Nishio
- Department of Thoracic Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan
| | - Y Ohe
- Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan
| | - T Tamura
- Thoracic Center, St. Luke's International Hospital, Tokyo, Japan
| | - N Yamamoto
- Internal Medicine III, Wakayama Medical University, Wakayama, Japan
| | - C-J Yu
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
| | - H Akamatsu
- Internal Medicine III, Wakayama Medical University, Wakayama, Japan
| | - Y Namba
- Clinical Science, Ono Pharmaceutical Co., Ltd., Osaka, Japan
| | - N Sumiyoshi
- Oncology Clinical Development Planning 1, Ono Pharmaceutical Co., Ltd., Osaka, Japan
| | - K Nakagawa
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan.
| |
Collapse
|
20
|
Affiliation(s)
- Takahiro Kozawa
- The Institute of Scientific and Industrial Research, Osaka University
| | | |
Collapse
|
21
|
Chida K, Kotani D, Moriwaki T, Fukuoka S, Masuishi T, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Komoda M, Makiyama A, Denda T, Hatachi Y, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Ando K, Yuki S, Okita Y, Kusaba H, Sakai D, Okamoto K, Tamura T, Yamashita K, Gosho M, Shimada Y. Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS). Front Oncol 2021; 11:576036. [PMID: 33763345 PMCID: PMC7982575 DOI: 10.3389/fonc.2021.576036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Accepted: 02/12/2021] [Indexed: 12/24/2022] Open
Abstract
Background: The survival benefits of regorafenib (REG) and trifluridine/tipiracil hydrochloride (TFTD) have been demonstrated in chemorefractory patients with metastatic colorectal cancer (mCRC). However, the effects of crossover administration of REG and TFTD on patient survival remain unclear. The present study evaluated the association between exposure to REG and TFTD and overall survival (OS) in patients with mCRC using data from the REGOTAS study. Patients and Methods: We analyzed patients registered in the REGOTAS study, which retrospectively compared the efficacy and safety of use of REG or TFTD as later-line chemotherapy for chemorefractory mCRC patients. We compared the survival outcomes of cohort A (treated using both REG and TFTD) and cohort B (treated using either REG or TFTD). Results: A total of 550 patients (cohort A, n = 252; cohort B, n = 298) met the inclusion criteria. The median OS was significantly increased in cohort A compared with cohort B [9.6 months (95% confidence interval (CI), 8.9–10.9 months) vs. 5.2 months (95% CI, 4.4–6.0 months), P < 0.001]. Multivariate analysis revealed that cohort A was independently associated with a significant increase in OS [A vs. B: Hazard ratios (HR), 0.58; 95% CI, 0.47–0.72; P < 0.001]. Subgroup analysis adjusted using multivariate Cox model revealed a consistently better trend in most subgroups for cohort A compared with cohort B. Conclusions: Our study revealed prolonged survival in patients treated with REG and TFTD. Therefore, all active agents, including REG and TFTD, should be made available to mCRC patients.
Collapse
Affiliation(s)
- Keigo Chida
- Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| | - Daisuke Kotani
- Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| | - Toshikazu Moriwaki
- Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
| | - Shota Fukuoka
- Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| | - Toshiki Masuishi
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan
| | - Atsuo Takashima
- Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
| | - Yosuke Kumekawa
- Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan
| | - Takeshi Kajiwara
- Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan
| | - Kentaro Yamazaki
- Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
| | - Masato Komoda
- Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
| | - Akitaka Makiyama
- Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.,Cancer Center, Gifu University Hospital, Gifu, Japan
| | - Tadamichi Denda
- Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan
| | - Yukimasa Hatachi
- Department of Medical Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan
| | - Takeshi Suto
- Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan
| | - Naotoshi Sugimoto
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Masanobu Enomoto
- Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan
| | - Toshiaki Ishikawa
- Department of Specialized Surgeries, Graduate School of Medicine and Dentistry, Tokyo Medical and Dental University, Tokyo, Japan
| | - Tomomi Kashiwada
- Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - Koji Ando
- Department Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Satoshi Yuki
- Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan
| | - Yoshihiro Okita
- Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan
| | - Hitoshi Kusaba
- Department of Medicine and Comprehensive Biosystemic Science, Kyushu University Graduate of Medical Sciences, Fukuoka, Japan
| | - Daisuke Sakai
- Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Koichi Okamoto
- Department of Surgery, National Defense Medical College, Tokorozawa, Japan
| | - Takao Tamura
- Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan
| | - Kimihiro Yamashita
- Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Hyogo, Japan
| | - Masahiko Gosho
- Department of Biostatistics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
| | - Yasuhiro Shimada
- Clinical Oncology Division, Kochi Health Sciences Center, Kochi, Japan
| |
Collapse
|
22
|
Yamaguchi K, Shimada Y, Hironaka S, Sugimoto N, Komatsu Y, Nishina T, Omuro Y, Tamura T, Piao Y, Homma G, Jen MH, Liepa AM, Muro K. Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial. Clin Drug Investig 2021; 41:53-64. [PMID: 33355909 PMCID: PMC7815617 DOI: 10.1007/s40261-020-00979-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/08/2020] [Indexed: 12/24/2022]
Abstract
BACKGROUND AND OBJECTIVE Gastric cancer has been associated with notable geographic heterogeneity in previous multi-regional studies. In particular, patients from Japan have better outcomes compared with patients from other regions. Here, we assess patient-focused outcomes for the subgroup of Japanese patients in the global RAINBOW study. METHODS Quality of life (QoL) was assessed using the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core 30 (QLQ-C30) at baseline and 6-week intervals. Investigators assessed performance status before each 4-week cycle. Time-to-deterioration in each QLQ-C30 scale was defined as randomization to first worsening of ≥ 10 points (on a 100-point scale). Time-to-deterioration in performance status was defined as first worsening to ≥ 2. Hazard ratios were estimated using Cox proportional hazards models. RESULTS The Japan subgroup contained 140 patients (ramucirumab plus paclitaxel, n = 68; placebo plus paclitaxel, n = 72); baseline QoL data were available for all patients. At baseline, QLQ-C30 scores were similar between study arms. Of the 15 QLQ-C30 scales, nine had a hazard ratio < 1, indicating similar or numerically longer time-to-deterioration in QoL for ramucirumab plus paclitaxel; all 95% confidence intervals included 1. Best mean change from baseline numerically favored ramucirumab plus paclitaxel in most QoL scales. The hazard ratios for time-to-deterioration of performance status to ≥ 2 were 0.64 in the Japan subgroup and 0.88 in the non-Asian subgroup. The Japan subgroup had better QoL at baseline compared with the non-Asian subgroup. CONCLUSIONS Treatment with ramucirumab plus paclitaxel maintained QoL and performance status over time compared with placebo plus paclitaxel in the Japan subgroup of the RAINBOW trial. These data suggest that the heterogeneity in gastric cancer between geographic regions includes multiple measures of QoL. TRIAL REGISTRATION NUMBER NCT01170663 (first submitted 21 July, 2010).
Collapse
Affiliation(s)
- Kensei Yamaguchi
- Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Yasuhiro Shimada
- Department of Clinical Oncology, Kochi Health Sciences Center, Kochi, Japan
| | - Shuichi Hironaka
- Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Oita, Japan
- Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan
| | - Naotoshi Sugimoto
- Department of Medical Oncology, Osaka International Cancer Institute, Chuo-ku, Osaka, Japan
| | - Yoshito Komatsu
- Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Hokkaido, Japan
| | - Tomohiro Nishina
- Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan
| | - Yasushi Omuro
- Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
| | - Takao Tamura
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Japan
| | - Yongzhe Piao
- Medicines Developmental Unit, Eli Lilly Japan K.K., Chuo-ku, Kobe, Japan
| | - Gosuke Homma
- Medicines Developmental Unit, Eli Lilly Japan K.K., Chuo-ku, Kobe, Japan
| | - Min-Hua Jen
- Eli Lilly and Company, Downshire Way, Bracknell, UK
| | | | - Kei Muro
- Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
| |
Collapse
|
23
|
Boku N, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Nishiyama T, Chen LT, Kang YK. Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab. Gastric Cancer 2021; 24:946-958. [PMID: 33743112 PMCID: PMC8205916 DOI: 10.1007/s10120-021-01173-w] [Citation(s) in RCA: 48] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Accepted: 02/12/2021] [Indexed: 02/07/2023]
Abstract
BACKGROUND ATTRACTION-2 demonstrated that nivolumab improved overall survival (OS) vs placebo in patients with advanced gastric cancer treated with ≥ 2 chemotherapy regimens. However, its long-term efficacy and outcome of treatment beyond progression (TBP) with nivolumab have not been clarified. METHODS The 3-year follow-up data were collected. A subset analysis was performed to explore the efficacy of TBP by assessing postprogression survival (PPS) after the first event of disease progression. RESULTS Overall, 493 patients were randomized (2:1) to receive nivolumab (n = 330) or placebo (n = 163). With a median follow-up of 38.5 (range 36.1-47.5) months, OS of the nivolumab group was significantly longer compared to the placebo group (median 5.3 vs 4.1 months; 3-year survival rate, 5.6% vs 1.9%; hazard ratio [HR], 0.62 [95% confidence interval (CI) 0.50-0.75], P < 0.0001). The median OS of responders (n = 32) who achieved complete response or partial response was 26.7 months and the 3-year survival rate was 35.5% in the nivolumab group. Overall, 109 patients in the nivolumab group and 37 patients in the placebo group received TBP. PPS tended to be longer in the nivolumab group vs placebo group (median 5.8 vs 4.5 months; HR [95% CI], 0.69 [0.47-1.01], P = 0.057). In contrast, PPS was similar between both treatment groups in non-TBP patients (median 2.3 vs 2.2 months; HR 0.90, P = 0.42). CONCLUSIONS Long-term efficacy of nivolumab was confirmed at the 3-year follow-up, and a survival benefit of TBP with nivolumab was suggested. Biomarkers for selecting patients suitable for TBP with nivolumab should be identified in the future.
Collapse
Affiliation(s)
- Narikazu Boku
- Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan
| | - Taroh Satoh
- Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan
| | - Min-Hee Ryu
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
| | - Yee Chao
- Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
| | - Ken Kato
- Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan
| | - Hyun Cheol Chung
- Division of Medical Oncology, Yonsei Cancer Center, Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea
| | - Jen-Shi Chen
- Division of Hematology and Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
| | - Kei Muro
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
| | - Won Ki Kang
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
, Seoul, South Korea
| | - Kun-Huei Yeh
- Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan ,Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan
| | - Takaki Yoshikawa
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan ,Present Address: Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
| | - Sang Cheul Oh
- Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, South Korea
| | - Li-Yuan Bai
- Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan
| | - Takao Tamura
- Department of Medical Oncology, Faculty of Medicine, Kindai University, Osakasayama, Japan ,Present Address: Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Keun-Wook Lee
- Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Yasuo Hamamoto
- Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan
| | - Jong Gwang Kim
- Kyungpook National University School of Medicine, Daegu, South Korea
| | - Keisho Chin
- Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Do-Youn Oh
- Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine
, Seoul, South Korea
| | - Keiko Minashi
- Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan
| | - Jae Yong Cho
- Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine
, Seoul, South Korea
| | - Masahiro Tsuda
- Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan
| | - Taihei Nishiyama
- Medical Information, Medical Affairs, Ono Pharmaceutical Co., Ltd., Osaka, Japan
| | - Li-Tzong Chen
- National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan ,National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan ,Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - Yoon-Koo Kang
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
| |
Collapse
|
24
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Bagliesi MG, Berti E, Bigongiari G, Binns WR, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Ebisawa K, Fuke H, Gonzi S, Guzik TG, Hams T, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kobayashi K, Kohri K, Krawczynski HS, Krizmanic JF, Link J, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori M, Mori N, Motz HM, Munakata K, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ospina N, Ozawa S, Pacini L, Palma F, Papini P, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Sparvoli R, Spillantini P, Stolzi F, Sugita S, Suh JE, Sulaj A, Takita M, Tamura T, Terasawa T, Torii S, Tsunesada Y, Uchihori Y, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K. Direct Measurement of the Cosmic-Ray Carbon and Oxygen Spectra from 10 GeV/n to 2.2 TeV/n with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2020; 125:251102. [PMID: 33416351 DOI: 10.1103/physrevlett.125.251102] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Revised: 09/01/2020] [Accepted: 11/19/2020] [Indexed: 06/12/2023]
Abstract
In this paper, we present the measurement of the energy spectra of carbon and oxygen in cosmic rays based on observations with the Calorimetric Electron Telescope on the International Space Station from October 2015 to October 2019. Analysis, including the detailed assessment of systematic uncertainties, and results are reported. The energy spectra are measured in kinetic energy per nucleon from 10 GeV/n to 2.2 TeV/n with an all-calorimetric instrument with a total thickness corresponding to 1.3 nuclear interaction length. The observed carbon and oxygen fluxes show a spectral index change of ∼0.15 around 200 GeV/n established with a significance >3σ. They have the same energy dependence with a constant C/O flux ratio 0.911±0.006 above 25 GeV/n. The spectral hardening is consistent with that measured by AMS-02, but the absolute normalization of the flux is about 27% lower, though in agreement with observations from previous experiments including the PAMELA spectrometer and the calorimetric balloon-borne experiment CREAM.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - Y Akaike
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M G Bagliesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - E Berti
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - C Checchia
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Gonzi
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwakecho, Sakyo, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| | - J Kataoka
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Hakubi Center, Kyoto University, Yoshida Honmachi, Sakyo-ku, Kyoto 606-8501, Japan
- Department of Astronomy, Graduate School of Science, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Kobayashi
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J Link
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology, Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508 Japan
| | - A A Moiseev
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - S Nakahira
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Ave., Denver, Colorado 80208-6900, USA
| | - N Ospina
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - S Ozawa
- Quantum ICT Advanced Development Center, National Institute of Information and Communications Technology, 4-2-1 Nukui-Kitamachi, Koganei, Tokyo 184-8795, Japan
| | - L Pacini
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - F Palma
- INFN Sezione di Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - K Sakai
- Center for Space Sciences and Technology, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Center for Research and Exploration in Space Sciences and Technology, NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - R Sparvoli
- INFN Sezione di Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
- University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - S Sugita
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - J E Suh
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 17 Kikuicho, Shinjuku, Tokyo 162-0044, Japan
| | - Y Tsunesada
- Division of Mathematics and Physics, Graduate School of Science, Osaka City University, 3-3-138 Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| |
Collapse
|
25
|
Yang JH, Mok T, Lu S, Nakagawa K, Yamamoto N, Shi YK, Zhang L, Soo R, Morita S, Tamura T. 396P Efficacy and safety of S-1 in elderly patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy: A subgroup analysis of the EAST-LC. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
26
|
Affiliation(s)
- S Ro
- From the Department of Pulmonary Medicine, Thoracic Center, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan
| | - R Imai
- From the Department of Pulmonary Medicine, Thoracic Center, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan
| | - T Tamura
- From the Department of Pulmonary Medicine, Thoracic Center, St. Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan
| |
Collapse
|
27
|
Ogata K, Murakami T, Yatabe K, Suzuki M, Nonaka I, Tamura T. REGISTRIES, CARE, QUALITY OF LIFE, MANAGEMENT OF NMD. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
Hosokawa A, Yamazaki K, Matsuda C, Ueda S, Kusaba H, Okamura S, Tsuda M, Tamura T, Shinozaki K, Tsushima T, Tsuda T, Shirakawa T, Yamashita H, Morita S, Hironaka S, Muro K. Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study. Medicine (Baltimore) 2020; 99:e22060. [PMID: 32899071 PMCID: PMC7478588 DOI: 10.1097/md.0000000000022060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
The phase III West Japan Oncology Group (WJOG) 4407G study showed noninferiority of folinic acid, bolus/continuous fluorouracil, and irinotecan plus bevacizumab to modified folinic acid, bolus/continuous fluorouracil, and oxaliplatin 6 plus bevacizumab in progression-free survival (PFS) as first-line chemotherapy for patients with metastatic colorectal cancer. The aim of this study was to evaluate the predictive and prognostic value of morphologic response in patients with colorectal liver metastases (CLM) as a post hoc analysis of the WJOG4407G study.Morphologic response was assessed by comparing contrast-enhanced computed tomography (CT) images at baseline and week 8. Three blinded radiologists evaluated CT images and classified their response as optimal, incomplete, or no response according to the morphologic criteria. Response evaluation criteria in solid tumors (RECIST) response, early tumor shrinkage (ETS), and depth of response (DpR) were also evaluated.Among 395 patients who were eligible for efficacy analysis in the WJOG4407G study, 70 patients had liver-limited disease. We finally evaluated 55 of these patients. Optimal morphologic response was identified in 19 of 55 patients (34.5%). The median PFS was 10.7 months for patients with optimal response and 10.1 months in those with incomplete/no response (log-rank, P = .96). The median overall survival (OS) was 26.2 and 35.5 months, respectively (log-rank, P = .062). According to univariate analysis, morphologic response was not associated with PFS or OS, whereas RECIST response was significantly associated with both PFS and OS, with ETS and DpR being associated with significantly longer PFS.Morphologic response might be neither a predictive nor a prognostic factor in patients with CLM undergoing chemotherapy containing bevacizumab, whereas RECIST response was significantly associated with both PFS and OS.
Collapse
Affiliation(s)
- Ayumu Hosokawa
- Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki
| | - Kentaro Yamazaki
- Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka
| | - Chu Matsuda
- Department of Surgery, Osaka General Medical Center, Osaka
| | - Shinya Ueda
- Department of Medical Oncology, Kindai University Nara Hospital, Nara
| | - Hitoshi Kusaba
- Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka
| | - Shu Okamura
- Department of Surgery, Suita Municipal Hospital, Suita
| | - Masahiro Tsuda
- Department of Gastroenterological Oncology, Hyogo Cancer Center, Hyogo
| | - Takao Tamura
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama
| | | | - Takahiro Tsushima
- Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka
| | - Takashi Tsuda
- Department of Clinical Oncology, St Marianna University School of Medicine, Kawasaki
| | - Tsuyoshi Shirakawa
- Department of Chemotherapy, Miyazaki Prefectural Miyazaki Hospital, Miyazaki
| | - Haruhiro Yamashita
- Department of Clinical Oncology, National Hospital Organization, Okayama Medical Center, Okayama
| | - Satoshi Morita
- Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto
| | - Shuichi Hironaka
- Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Yufu
| | - Kei Muro
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
| |
Collapse
|
29
|
Lee JS, Sugawara S, Kang J, Kim H, Inui N, Hida T, Lee K, Yoshida T, Tanaka H, Yang C, Nishio M, Ohe Y, Tamura T, Yamamoto N, Yu CJ, Akamatsu H, Namba Y, Sumiyoshi N, Nakagawa K. LBA54 Randomized phase III trial of nivolumab in combination with carboplatin, paclitaxel, and bevacizumab as first-line treatment for patients with advanced or recurrent non-squamous NSCLC. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.2287] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
30
|
Kurosaki T, Kawakami H, Mitani S, Kawabata R, Takahama T, Nonagase Y, Fumita S, Ozaki T, Chiba Y, Tamura T, Nakagawa K. Glasgow Prognostic Score (GPS) and Tumor Response as Biomarkers of Nivolumab Monotherapy in Third- or Later-line Setting for Advanced Gastric Cancer. In Vivo 2020; 34:1921-1929. [PMID: 32606164 DOI: 10.21873/invivo.11989] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Revised: 04/11/2020] [Accepted: 04/16/2020] [Indexed: 01/05/2023]
Abstract
BACKGROUND/AIM This study aimed to seek clinical biomarkers of nivolumab monotherapy for advanced gastric cancer (AGC) of which efficacy is limited. We focused on Glasgow Prognostic Score (GPS), which reflects systemic inflammatory and nutritional status as well as disease control by chemotherapy immediately before nivolumab (DCBC). PATIENTS AND METHODS AGC patients with measurable lesions who were treated with nivolumab in the third- or later-line were included. DCBC was defined as a best overall response of complete response (CR), partial response, stable disease, or non-CR/non-progressive disease achieved by chemotherapy immediately before nivolumab. RESULTS Eighty patients were analyzed. Among the various clinical factors, multivariable analysis revealed that a GPS of 2 was significantly associated with a shorter overall survival and DCBC was significantly associated with a longer progression-free survival. CONCLUSION We present the potential of GPS and DCBC as efficient biomarkers of nivolumab for AGC, that warrants further evaluation.
Collapse
Affiliation(s)
- Takashi Kurosaki
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
| | - Hisato Kawakami
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
| | - Seiichiro Mitani
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
| | | | - Takayuki Takahama
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Yoshikane Nonagase
- Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Japan
| | - Soichi Fumita
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
| | - Tomohiro Ozaki
- Department of Medical Oncology, Kishiwada City Hospital, Kishiwada, Japan
| | - Yasutaka Chiba
- Clinical Research Center, Kindai University Hospital, Osaka-Sayama, Japan
| | - Takao Tamura
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Kazuhiko Nakagawa
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
| |
Collapse
|
31
|
Tsujie M, Fumita S, Wakasa T, Mizuno S, Ishikawa H, Kitani K, Satoi S, Okada K, Inoue K, Fukuda S, Manabe H, Ichimura N, Ueda S, Tamura T, Kawasaki T, Yukawa M, Ohta Y, Inoue M. A Case of Pathological Complete Response Following FOLFIRINOX Therapy for Pancreatic Adenocarcinoma with Synchronous Distant Lymph Node Metastases. Int J Surg Case Rep 2020; 72:471-476. [PMID: 32698268 PMCID: PMC7322239 DOI: 10.1016/j.ijscr.2020.06.044] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2020] [Revised: 05/24/2020] [Accepted: 06/03/2020] [Indexed: 02/07/2023] Open
Abstract
INTRODUCTION We report a case of conversion surgery for pancreatic ductal adenocarcinoma (PDAC) with synchronous distant metastases showing pathological complete response (pCR) after FOLFIRINOX therapy. PRESENTATION OF CASE A 46-year-old woman with obstructive jaundice was referred to our hospital. A CT scan revealed a hypo-vascular mass in the head of the pancreas with multiple para-aortic lymph nodes and a Virchow's node swollen. The serum CA 19-9 level was 71795.1 U/mL. The result of tumor biopsy from the biliary stenotic site was concordant with adenocarcinoma. She was diagnosed with PDAC with distant metastases. After 10 courses of FOLFIRINOX followed by 4 courses of FOLFIRI, a CT scan showed that distant lymph node swellings disappeared, and CA19-9 level became almost normal. She underwent pancreaticoduodenectomy with dissection of para-aortic lymph nodes 8 months after the initiation of chemotherapy. Pathologically, no evidence of residual adenocarcinoma was observed in neither pancreas nor lymph nodes. Adjuvant chemotherapy using S-1 was administered for 6 months, and no recurrence has been observed 4 years after surgery. BRCA1/2 mutations were not detected in patient's DNA. DISCUSSION With the induction of intensive chemotherapies such as FOLFIRINOX, an increasing number of patients with synchronous distant metastases could become suitable candidates for surgery of the primary lesion because of the potential complete response of metastatic lesions. CONCLUSION This case presented a rare occurrence of pCR in a patient with unresectable PDAC with distant metastases who received FOLFIRINOX. The feasibility and benefits of conversion surgery in such patients must be investigated in future trials.
Collapse
Affiliation(s)
- Masanori Tsujie
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan; Department of Surgery, Osaka Rosai Hospital, Japan.
| | - Soichi Fumita
- Department of Medical Oncology, Kindai University Nara Hospital, Japan.
| | - Tomoko Wakasa
- Department of Pathology, Kindai University Nara Hospital, Japan.
| | - Shigeto Mizuno
- Department of Endoscopic Diagnosis and Treatment, Kindai University Nara Hospital, Japan.
| | - Hajime Ishikawa
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| | - Kotaro Kitani
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| | - Shumpei Satoi
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| | - Kaoru Okada
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| | - Keisuke Inoue
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| | - Shuichi Fukuda
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| | - Hironobu Manabe
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| | - Noriko Ichimura
- Department of Nursing, Kindai University Nara Hospital, Japan.
| | - Shinya Ueda
- Department of Medical Oncology, Kindai University Nara Hospital, Japan.
| | - Takao Tamura
- Department of Medical Oncology, Kindai University Nara Hospital, Japan.
| | | | - Masao Yukawa
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| | - Yoshio Ohta
- Department of Pathology, Kindai University Nara Hospital, Japan.
| | - Masatoshi Inoue
- Department of Gastroenterological Surgery, Kindai University Nara Hospital, Japan.
| |
Collapse
|
32
|
Kawakami H, Fujitani K, Matsuyama J, Akamaru Y, Tamura S, Endo S, Kimura Y, Makari Y, Tamura T, Sugimoto N, Sakai D, Tsujinaka T, Goto M, Kurokawa Y, Shimokawa T, Satoh T. Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials. Int J Clin Oncol 2020; 25:1635-1643. [PMID: 32494981 DOI: 10.1007/s10147-020-01711-z] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2020] [Accepted: 05/21/2020] [Indexed: 01/07/2023]
Abstract
BACKGROUND We previously reported the HERBIS-4A phase II trial comparing S-1 plus cisplatin (SP) with capecitabine plus cisplatin (XP) in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (GC). We performed a pooled analysis of HERBIS-4A and HERBIS-2, the phase II trial comparing SP with XP in HER2-negative recurrent GC patients with a recurrence-free interval after S-1 adjuvant therapy of ≥ 6 months. PATIENTS AND METHODS Patients were randomly assigned to receive either SP [S-1 (40-60 mg twice daily for 21 days) plus cisplatin (60 mg/m2 on day 8), every 5 weeks] or XP [capecitabine (1000 mg/m2 twice daily for 14 days) plus cisplatin (80 mg/m2 on day 1), every 3 weeks]. RESULTS In the pooled analysis, SP (n = 44-50) showed a longer progression-free survival [6.4 versus 5.1 months; hazard ratio (HR), 0.666; P = 0.062], overall survival (14.8 versus 10.6 months; HR, 0.695; P = 0.099), and time to treatment failure (4.6 versus 3.6 months; HR, 0.668; P = 0.045) as well as a higher disease control rate (86.4% versus 68.1%, P = 0.149) compared with XP (n = 47-51). A significant survival advantage for SP over XP was apparent in patients with a performance status of 0, a differentiated-type tumor histology, or a primary tumor localization to the upper portion of the stomach. CONCLUSION Our pooled analysis supports the use of SP in the first-line setting for patients with HER2-negative advanced or recurrent GC with a recurrence-free interval of ≥ 6 months. CLINICAL TRIAL REGISTRATION The HERBIS-2 trial was registered with UMIN-CTR as UMIN000006105.
Collapse
Affiliation(s)
- Hisato Kawakami
- Department of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Ohno-higashi, Osaka-sayama, Osaka, 589-8511, Japan.
| | - Kazumasa Fujitani
- Department of Surgery, Osaka Prefectural General Medical Center, Osaka-shi, Japan
| | - Jin Matsuyama
- Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan
| | - Yusuke Akamaru
- Department of Surgery, Ikeda Municipal Hospital, Ikeda, Japan
| | | | - Shunji Endo
- Department of Surgery, Faculty of Medicine, Kindai University, Osaka-sayama, Japan
| | - Yutaka Kimura
- Department of Surgery, Sakai City Medical Center, Sakai, Japan
| | - Youichi Makari
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Takao Tamura
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Naotoshi Sugimoto
- Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan
| | - Daisuke Sakai
- Cancer Center, Izumi City General Hospital, Izumi, Japan
| | - Toshimasa Tsujinaka
- Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan
| | - Masahiro Goto
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| | - Yukinori Kurokawa
- Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan
| | - Toshio Shimokawa
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan
| | - Taroh Satoh
- Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan
| |
Collapse
|
33
|
Tamura T, Chida Y, Okada K. Short communication: Detection of mastication speed during rumination in cattle using 3-axis, neck-mounted accelerometers and fast Fourier transfer algorithm. J Dairy Sci 2020; 103:7180-7187. [PMID: 32505412 DOI: 10.3168/jds.2019-17611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2019] [Accepted: 03/24/2020] [Indexed: 11/19/2022]
Abstract
There have been limited reports on mastication speed during cattle rumination. The objective of this study was to establish a method to detect mastication speed based on data obtained during rumination through the use of a 3-axis accelerometer attached to the neck. A 3-axis accelerometer was attached to 6 dry Holstein cattle. When rumination behavior was observed, the accelerometer and the high-speed camera simultaneously recorded acceleration at the neck and moving image of the head movement. Based on the number of mastication movements recorded on video, mastication speed A was calculated. Data obtained from the 3-axis accelerometer were analyzed with fast Fourier transfer algorithm and identified as mastication speed B. The vibration of the neck recorded in the accelerometer during rumination was considered as mastication movement. Using Bland-Altman plot analysis, the mean difference between mastication speed A and mastication speed B was 0.041 s/bite, and the 95% limits of agreement ranged from -0.080 to 0.161. Since mastication movement occurred periodically, it was possible to detect the movement using spectrum analysis, as mastication speed B. Although there were some differences between calculated speeds and speeds obtained from spectrum analysis, there was clinical compatibility between mastication speed A and B. This study showed the feasibility of establishing a detection method for mastication speed during rumination, which might provide a basic procedure for studying the purpose of mastication and the variable factors involved.
Collapse
Affiliation(s)
- T Tamura
- United Graduate School of Veterinary Sciences, Gifu University, Gifu 501-1193, Japan; Iwate Agricultural Mutual Aid Association, Morioka 020-0857, Japan
| | - Y Chida
- Bycen Co. Ltd., Kobe 651-2275, Japan
| | - K Okada
- United Graduate School of Veterinary Sciences, Gifu University, Gifu 501-1193, Japan; Cooperate Department of Veterinary Medicine, Iwate University, Morioka 020-8550, Japan.
| |
Collapse
|
34
|
Suzuki T, Aoki M, Shirasu H, Takahashi N, Nakatsuka R, Ando T, Kito Y, Yamamoto Y, Kawakami K, Matsumoto T, Shimozaki K, Nagase M, Yamaguchi T, Negoro Y, Tamura T, Amanuma Y, Esaki T, Miura Y, Nagashima K, Boku N. Hyperprogressive disease during nivolumab chemotherapy in metastatic gastric cancer: Multicenter retrospective study in Japan. J Clin Oncol 2020. [DOI: 10.1200/jco.2020.38.4_suppl.377] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
377 Background: Nivolumab has demonstrated a survival benefit for advanced gastric cancer (AGC). However, hyperprogressive disease (HPD) has been reported in various cancers. Methods: The subjects of this retrospective study were AGC patients with measurable disease who received nivolumab, and their tumors were assessed at least 3 times (during prior therapy, before and after nivolumab) in 24 institutions. Tumor growth rates (TGR) during nivolumab were compared to those during prior therapy as reported (Champiat S, 2017). HPD was defined as an increase in TGR > 2-fold. Results: 218 patients were identified as the subjects. While 33 (15.1%) partial response (PR) were achieved, 130 patients (59.6%) showed progression disease (PD), 38 of whom were classified as HPD (17.4%) and 2 patients showed pseudo progression (1.0%). The median progression-free survival (PFS) was 1.9 months (95% CI: 1.9–2.4) and the median overall survival (OS) was 8.5 months (95% CI: 7.1–9.6) in all patients. While patients with PD showed shorter prognosis compared with non-PD patients (median PFS: 1.5 months vs 6.4 months, hazard ratio; 6.0 [95% CI: 4.3–8.4]; p < 0.0001; median OS: 4.7 months vs not reached, hazard ratio; 4.1 [95% CI: 2.8–6.3]; p < 0.0001), there were no differences either in PFS or OS between patients with HPD and those with PD other than HPD (median PFS: 1.5 months vs 1.6 months, hazard ratio; 1.3 [95% CI: 0.9–2.0]; p = 0.1194; median OS: 5.0 months vs 4.6 months, hazard ratio; 1.0 [95% CI: 0.6–1.5]; p = 0.8695). Histological type, liver metastases, carbohydrate antigen 19-9 (CA19-9) level were associated with HPD. Conclusions: HPD was observed 17.4% in AGC patients treated with nivolumab. There were no differences either in PFS or OS between patients with HPD and those with PD other than HPD. Clinicopathological characteristics might be a predict factor for HPD.
Collapse
Affiliation(s)
- Takeshi Suzuki
- Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
| | | | - Hiromichi Shirasu
- Division of Clinical Oncology, Shizuoka Cancer Center, Shizuoka, Japan
| | | | - Rie Nakatsuka
- Department of Surgery, Osaka General Medical Center, Osaka, Japan
| | - Takayuki Ando
- Third Department of Internal Medicine, University of Toyama, Toyama, Japan
| | - Yosuke Kito
- Department of Medical Oncology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan
| | | | - Kentaro Kawakami
- Department of Medical Oncology, Keiyukai Sapporo Hospital, Sapporo, Japan
| | | | | | - Michitaka Nagase
- Department of Clinical Oncology, Jichi Medical University, Shimotsuke, Japan
| | - Toshifumi Yamaguchi
- Department of Cancer Chemotherapy Center, Osaka Medical Collage Hospital, Osaka, Japan
| | - Yuji Negoro
- Department of Gastroenterology, Kochi Health Sciences Center, Kochi, Japan
| | - Takao Tamura
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Yusuke Amanuma
- Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan
| | - Taito Esaki
- National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
| | - Yuji Miura
- Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan
| | - Kengo Nagashima
- Research Center for Medical and Health Data Science, The Institute of Statistical Mathematics, Tokyo, Japan
| | | |
Collapse
|
35
|
Matsuyama J, Kawakami H, Fujitani K, Akamaru Y, Tamura S, Endo S, Kimura Y, Makari Y, Tamura T, Sugimoto N, Sakai D, Tsujinaka T, Goto M, Kurokawa Y, Shimokawa T, Satoh T. Comparing five-weekly S-1 plus cisplatin with tri-weekly capecitabine plus cisplatin in patients with HER2-negative recurrent gastric cancer after S-1 adjuvant therapy or chemotherapy naïve advanced gastric cancer: A pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials. J Clin Oncol 2020. [DOI: 10.1200/jco.2020.38.4_suppl.379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
379 Background: HERBIS-2 trial was a phase II trial where S-1 plus cisplatin (SP) and capecitabine plus cisplatin (XP) were compared in recurrent HER2 negative gastric cancer (GC) patients with recurrence free interval (RFI) by S-1containing adjuvant of ≥ 6 months. We performed pooled analyses of HERBIS-2 and HERBIS-4A trial where SP and XP were compared in chemotherapy-naive HER2 negative gastric cancer (GC) patients as these trials being identical. Methods: Both HERBIS-2 and 4A trials, patients were randomly assigned to receive either SP (S-1 at 40–60 mg twice daily for 21 days plus cisplatin at 60 mg/ m2on day 8, every 5 weeks) or XP (capecitabine 1,000 mg/m2twice daily for 14 days plus cisplatin 80 mg/m2on day 1, every 3 weeks). Results: In HERBIS-2 which was s closed early due to poor accrual, SP ( N= 10) tended to confer a better overall survival (OS) compared with XP ( N= 9)[18.7 (95%CI, 2.8 – NR) months vs.13.4 (95% CI, 5.2 – 31.3) months; hazard ratio (HR), 0.443 (95% CI, 0.156 – 1.258); P= .117]. In pooled analyses with HERBIS-2 and 4A, SP ( N= 50) vs. XP ( N = 51) showed longer progression free survival (6.4 vs.5.1 months; HR, 0.666; P= .62), OS (14.8 vs. 10.6 months; HR, 0.695; P= .099), time to treatment failure (4.6 vs. 3.6 months; HR, 0.668; P= .045), and higher disease control rate (86.4% vs. 68.1%, P= .149). Subgroup analysis revealed that OS benefit in SP arm compared to XP arm was significantly larger if the patient having PS of 0 [HR, 0.554 (95% CI, 0.309 to 0.959; interaction P= .035], or the tumor arising from upper area of stomach [HR, 0.266 (95% CI, 0.070 to 0.731); interaction P= .013] or harboring differentiated type cancer [HR, 0.433 (95% CI, 0.228 to 0.822); interaction P= .011], respectively. Conclusions: Our data suggest the use of SP in the 1stline setting in HER2 negative advanced or recurrent GC with RFI by S-1 adjuvant of ≥ 6 months. Pooled analyses further suggest SP as the standard 1st line chemotherapy for HER2 negative AGC irrespective of S-1 adjuvant in Japan. Clinical trial information: UMIN000006755/UMIN000006105.
Collapse
Affiliation(s)
- Jin Matsuyama
- Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan
| | - Hisato Kawakami
- Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Japan
| | | | - Yusuke Akamaru
- Department of Surgery, Ikeda Municipal Hospital, Ikeda, Japan
| | | | - Shunji Endo
- Yao Municipal Hospital, Yao City, Osaka, Japan
| | | | | | - Takao Tamura
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | | | | | | | - Masahiro Goto
- Department of Cancer Chemotherapy Center, Osaka Medical Collage Hospital, Osaka, Japan
| | - Yukinori Kurokawa
- Department of Gastroenterological Surgery, Osaka University, Graduate School of Medicine, Suita City, Osaka, Japan
| | - Toshio Shimokawa
- Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG), Osaka, Japan
| | | |
Collapse
|
36
|
Chen LT, Kang YK, Satoh T, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang W, Yoshikawa T, Oh SC, Tamura T, Lee KW, Boku N. A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data. J Clin Oncol 2020. [DOI: 10.1200/jco.2020.38.4_suppl.383] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
383 Background: Nivo is the first immune checkpoint inhibitor (ICI) to show efficacy and tolerability in G/GEJ cancer patients refractory to or intolerant of standard chemotherapy. Although Nivo has demonstrated durable efficacy in several cancer types, no long-term efficacy data in G/GEJ cancer has been reported to date. Here, we report the 3-year survival data of Nivo in G/GEJ cancer. Methods: A total of 493 patients with unresectable advanced or recurrent G/GEJ cancer after the failure of two or more chemotherapy regimens were randomized in a 2:1 ratio to receive 3 mg/kg Nivo (N = 330) or placebo (N = 163) until disease progression or unacceptable toxicity. The primary endpoint was overall survival (OS). Updated results of the efficacy and safety were based on ≥ 3 years of follow-up after last patient enrollment. In subgroup analysis, we evaluated OS by BOR and incidence of select treatment-related adverse events (TRAEs). Results: As of data cut-off in February 2019, 3 years after last patient enrollment, the hazard ratios of OS and PFS in the Nivo group compared with the placebo group remained 0.62 and 0.60, respectively. The 36-month OS rates of Nivo and placebo were 5.6% and 1.2 % and the 36-month PFS rates were 2.4% and 0%, respectively. In the OS subgroup analysis by BOR, the median OS and 3-year OS rate in CR/PR patients with Nivo were 26.7 months and 35.5%, respectively. The incidence rate and severity of TRAEs were comparable with those of the 2-year cut-off. In the OS subgroup analysis based on the presence or absence of select TRAEs, the hazard ratio in patients with select TRAEs was 0.46 compared to those without select TRAEs. We are analyzing the baseline characteristics that are associated with long-term survival with Nivo. Conclusions: Nivo showed durable efficacy and a good safety profile on long-term follow-up in heavily pretreated G/GEJ cancer patients. Clinical trial information: NCT02267343.
Collapse
Affiliation(s)
| | | | | | - Yee Chao
- Taipei Veterans General Hospital, Taipei City, Taiwan
| | - Ken Kato
- National Cancer Center Hospital, Tokyo, Japan
| | - Hyun Cheol Chung
- Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
| | - Jen-Shi Chen
- Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
| | - Kei Muro
- Department of Clinical Oncology, Cancer Center Hospital, Nagoya, Japan
| | - WonKi Kang
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | | | | | - Takao Tamura
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Keun Wook Lee
- Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | | |
Collapse
|
37
|
Abstract
Abstract
Background/Introduction
Cather ablation (CA) for atrial fibrillation (AF) as rhythm control therapy has widely spread. However, the indication of CA for the patients with asymptomatic AF is controversial (2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS).
Purpose
This study was aimed to examine the effect of CA for asymptomatic AF patients.
Methods
In a total of 522 consecutive patients who were hospitalized for the initial CA for AF, 123 patients (23.6%) who were asymptomatic were retrospectively analyzed. "Asymptomatic AF" was defined when the patients had no complaints during the medical interviews. Quality of life (QOL) was evaluated with the AF QOL Questionnaire score (AFQLQ, invented by the Japanese Society of Electrocardiology) before CA and at 1 year after a single CA.
Results
A total of 79 patients were persistent AF (64.2%). Sinus rhythm maintenance rate at 3 yeas after CA was 57.0% in a single session and 84.8% in multiple sessions. In cardiac echo data at baseline, 3 months, 6 months, and 1 year after CA, left ventricular ejection fraction (LVEF) and left atrium diameter (LAD) were improved in the initial three months after a single CA (LVEF; 62.8 ± 8.0%→64.4 ± 6.5%, p = 0.045, LAD; 39.7 ± 6.1mm→35.3 ± 7.0mm, p = 0.0002). In LA volume measured with CT before and after CA, LA reverse remodeling was observed (102.7 ± 32.3ml→72.4 ± 24.1ml, p<.0001). In AFQLQ2 (severity of symptoms), there was no significant difference (16.3 ± 2.2→15.9 ± 1.7 out of 18, p = 0.69). However, in AFQLQ1 (frequency of symptoms) and AFQLQ3 (limitations of activities and mental anxiety), the score was improved (20.2 ± 4.5→23.4 ± 1.1 out of 24, p<.0001 and 47.6 ± 7.8→51.3 ± 6.1 out of 56, p = 0.0001). Moreover, in low LVEF patients (LVEF < 50%, n = 8), LVEF was remarkably improved (44.1 ± 4.0%→56.3 ± 10.8%, p = 0.034).
Conclusions
The improvement of LVEF and LA reverse remodeling can be expected at the early stage after CA, because of the reduction of AF burden. Moreover, the further improvement of QOL can be expected after CA, even in the patients with "asymptomatic" AF.
Collapse
Affiliation(s)
- N Onishi
- Japanese Red Cross Otsu Hospital, Otsu, Japan
| | - M Oi
- Japanese Red Cross Otsu Hospital, Otsu, Japan
| | - T Jinnai
- Japanese Red Cross Otsu Hospital, Otsu, Japan
| | - K Kaitani
- Japanese Red Cross Otsu Hospital, Otsu, Japan
| | - T Harita
- Tenri Hospital, Department of Cardiology, Tenri, Nara, Japan
| | - S Nishiuchi
- Tenri Hospital, Department of Cardiology, Tenri, Nara, Japan
| | - T Tamura
- Tenri Hospital, Department of Cardiology, Tenri, Nara, Japan
| |
Collapse
|
38
|
Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N. A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data. Gastric Cancer 2020; 23:510-519. [PMID: 31863227 PMCID: PMC7165140 DOI: 10.1007/s10120-019-01034-7] [Citation(s) in RCA: 175] [Impact Index Per Article: 43.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Accepted: 12/10/2019] [Indexed: 02/07/2023]
Abstract
BACKGROUND Nivolumab showed improvement in overall survival (OS) in ATTRACTION-2, the first phase 3 study in patients with gastric/gastroesophageal junction (G/GEJ) cancer treated with ≥ 2 chemotherapy regimens. The 2-year follow-up results of ATTRACTION-2 are presented herein. METHODS ATTRACTION-2 was a randomized, double-blind, placebo-controlled, phase 3 trial (49 sites; Japan, South Korea, and Taiwan). The median (min-max) follow-up period was 27.3 (24.1-36.3) months. The primary endpoint was OS. A subanalysis of OS was performed based on best overall response and tumor-programmed death ligand-1 (PD-L1) expression status. RESULTS Overall, 493 of 601 screened patients were randomized (2:1) to receive nivolumab (330) or placebo (163). OS (median [95% confidence interval; CI]) was significantly longer in the nivolumab group (5.26 [4.60-6.37] vs 4.14 [3.42-4.86] months in placebo group) at the 2-year follow-up (hazard ratio [95% CI], 0.62 [0.51-0.76]; P < 0.0001). A higher OS rate was observed in the nivolumab vs placebo group at 1 (27.3% vs 11.6%) and 2 years (10.6% vs 3.2%). The OS benefit was observed regardless of tumor PD-L1 expression. Among patients with a complete or partial response (CR or PR) in the nivolumab group, the median OS (95% CI) was 26.6 (21.65-not applicable) months; the OS rates at 1 and 2 years were 87.1% and 61.3%, respectively. No new safety signals were identified. CONCLUSIONS Nivolumab treatment resulted in clinically meaningful long-term improvements in OS in patients with previously treated G/GEJ cancer. The long-term survival benefit of nivolumab was most evident in patients with a CR or PR.
Collapse
Affiliation(s)
- Li-Tzong Chen
- grid.64523.360000 0004 0532 3255National Institute of Cancer Research, National Health Research Institutes, National Cheng Kung University, Tainan, Taiwan ,grid.64523.360000 0004 0532 3255Department of Internal Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan
| | - Taroh Satoh
- grid.136593.b0000 0004 0373 3971Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan
| | - Min-Hee Ryu
- grid.267370.70000 0004 0533 4667Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Yee Chao
- grid.278247.c0000 0004 0604 5314Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
| | - Ken Kato
- grid.272242.30000 0001 2168 5385Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan
| | - Hyun Cheol Chung
- grid.413046.40000 0004 0439 4086Division of Medical Oncology, Yonsei Cancer Center, Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea
| | - Jen-Shi Chen
- grid.145695.aDivision of Hematology and Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
| | - Kei Muro
- grid.410800.d0000 0001 0722 8444Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
| | - Won Ki Kang
- grid.264381.a0000 0001 2181 989XDivision of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Kun-Huei Yeh
- grid.19188.390000 0004 0546 0241National Taiwan University Cancer Center, Taipei, Taiwan ,grid.19188.390000 0004 0546 0241Department of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan
| | - Takaki Yoshikawa
- grid.414944.80000 0004 0629 2905Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan ,grid.272242.30000 0001 2168 5385Present Address: Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
| | - Sang Cheul Oh
- grid.222754.40000 0001 0840 2678Division of Hematology and Oncology, Department of Internal Medicine, College of Medicine, Korea University, Seoul, South Korea
| | - Li-Yuan Bai
- grid.254145.30000 0001 0083 6092Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan
| | - Takao Tamura
- grid.258622.90000 0004 1936 9967Department of Medical Oncology, Faculty of Medicine, Kindai University, Osakasayama, Japan ,grid.258622.90000 0004 1936 9967Present Address: Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Keun-Wook Lee
- grid.31501.360000 0004 0470 5905Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Yasuo Hamamoto
- grid.26091.3c0000 0004 1936 9959Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan
| | - Jong Gwang Kim
- grid.258803.40000 0001 0661 1556Kyungpook National University School of Medicine, Daegu, South Korea
| | - Keisho Chin
- grid.410807.a0000 0001 0037 4131Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Do-Youn Oh
- grid.412484.f0000 0001 0302 820XDepartment of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
| | - Keiko Minashi
- grid.418490.00000 0004 1764 921XClinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan
| | - Jae Yong Cho
- grid.15444.300000 0004 0470 5454Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - Masahiro Tsuda
- grid.417755.5Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan
| | - Hiroki Sameshima
- grid.459873.40000 0004 0376 2510Medical Oncology, Medical Affairs, Ono Pharmaceutical Co., Ltd., Osaka, Japan
| | - Yoon-Koo Kang
- grid.267370.70000 0004 0533 4667Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
| | - Narikazu Boku
- grid.272242.30000 0001 2168 5385Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045 Japan
| |
Collapse
|
39
|
Satoh T, Kang YK, Chao Y, Ryu MH, Kato K, Cheol Chung H, Chen JS, Muro K, Ki Kang W, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Tanimoto M, Chen LT, Boku N. Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer. Gastric Cancer 2020; 23:143-153. [PMID: 31087200 PMCID: PMC6942596 DOI: 10.1007/s10120-019-00970-8] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2019] [Accepted: 04/29/2019] [Indexed: 02/07/2023]
Abstract
BACKGROUND Data on immune checkpoint inhibitor efficacy in patients with human epidermal growth factor receptor 2-positive (HER2+) advanced gastric/gastroesophageal junction (G/GEJ) cancer are lacking. Because HER2 status was not captured in the ATTRACTION-2 trial, we used patients with prior trastuzumab use (Tmab+) as surrogate for HER2 expression status to evaluate the efficacy and safety of nivolumab as third- or later-line therapy in these patients. METHODS In ATTRACTION-2, a randomized, double-blind, placebo-controlled, phase 3 multicenter trial, patients were randomized (2:1) to receive nivolumab (3 mg/kg) or placebo every 2 weeks until disease progression or toxicity requiring study discontinuation. Overall survival (OS), progression-free survival (PFS), objective response rate (ORR), and safety were assessed. RESULTS Of 493 enrolled patients, 81 (nivolumab, n = 59; placebo, n = 22) were Tmab+ and 412 (nivolumab, n = 271; placebo, n = 141) were Tmab-. In both groups, patients receiving nivolumab showed a longer median OS vs placebo (Tmab+, 8.3 [95% confidence interval, 5.3-12.9] vs 3.1 [1.9-5.3] months, hazard ratio, 0.38 [0.22-0.66]; P = 0.0006; Tmab-, 4.8 [4.1-6.0] vs 4.2 [3.6-4.9] months, 0.71 [0.57-0.88]; P = 0.0022). PFS was longer in both groups receiving nivolumab vs placebo (Tmab+, 1.6 [1.5-4.0] vs 1.5 [1.3-2.9] months, 0.49 [0.29-0.85]; P = 0.0111; Tmab-, 1.6 [1.5-2.4] vs 1.5 [1.5-1.5] months, 0.64 [0.51-0.80]; P = 0.0001). CONCLUSIONS Nivolumab was efficacious and safe as third- or later-line therapy regardless of prior trastuzumab use in patients with advanced G/GEJ cancer.
Collapse
Affiliation(s)
- Taroh Satoh
- Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan
| | - Yoon-Koo Kang
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
| | - Yee Chao
- Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
| | - Min-Hee Ryu
- Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
| | - Ken Kato
- Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan
| | - Hyun Cheol Chung
- Division of Medical Oncology, Yonsei Cancer Center, Song-Dang Institute for Cancer Research, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea
| | - Jen-Shi Chen
- Division of Hematology and Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
| | - Kei Muro
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
| | - Won Ki Kang
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Kun-Huei Yeh
- Department of Oncology, National Taiwan University Hospital, and National Taiwan University Cancer Center, Taipei, Taiwan
| | - Takaki Yoshikawa
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
- Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
| | - Sang Cheul Oh
- Division of Hematology and Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
| | - Li-Yuan Bai
- Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan
| | - Takao Tamura
- Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan
- Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan
| | - Keun-Wook Lee
- Division of Hematology and Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea
| | - Yasuo Hamamoto
- Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan
| | - Jong Gwang Kim
- School of Medicine, Kyungpook National University, Daegu, South Korea
| | - Keisho Chin
- Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
| | - Do-Youn Oh
- Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
| | - Keiko Minashi
- Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan
| | - Jae Yong Cho
- Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - Masahiro Tsuda
- Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan
| | - Mitsunobu Tanimoto
- Oncology Clinical Development Planning, Oncology Clinical Development Unit, ONO Pharmaceutical Co., Ltd., Osaka, Japan
| | - Li-Tzong Chen
- National Institute of Cancer Research, National Health Research Institutes, and National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan
| | - Narikazu Boku
- Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
| |
Collapse
|
40
|
Matsutani H, Amano M, Izumi C, Baba M, Abe R, Hashiwada S, Kuwano K, Shimada M, Sakamoto J, Miyake M, Tamura T, Matsuo S. P1444 Occurrence and predictors of right ventricular dysfunction after pericardiocentesis. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.872] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background—The changes in cardiac function that occur after pericardiocentesis are unclear.Purpose—This study was performed to assess right ventricular (RV) and left ventricular (LV) function with echocardiography before and after pericardiocentesis.
Method and Results—In total, 19 consecutive patients who underwent pericardiocentesis for more than moderate pericardial effusion were prospectively enrolled from August 2015 to October 2017. Comprehensive transthoracic echocardiography was performed before, immediately after (within 3 hours), and 1 day after pericardiocentesis to investigate the changes in RV and LV function. RV dysfunction is defined as meeting three of the four criteria: a TAPSE of <17 mm, an S’ of <9.5 cm, an FAC of <35%, and an RV free wall longitudinal strain >−20%. The mean age of all patients was 72.6 ± 12.2 years. The changes of echocardiographic parameters related to RV function are shown in Table. After pericardiocentesis, RV inflow and outflow diameters increased and the parameters of RV function significantly decreased. These abnormal values or RV dysfunction remained at 1 day after pericardiocentesis. Conversely, no parameters of LV function parameters changed after pericardiocentesis. Of 19 patients, 13 patients showed RV dysfunction immediately after pericardiocentesis and 6 patients did not. RV free wall longitudinal strain before pericardiocentesis was higher in patients with post-procedural RV dysfunction (−18.9 ± 3.6%) than in those without (−28.4 ± 6.3%). ROC analysis revealed that a RV free wall longitudinal strain cut-off value of −23.0% had a sensitivity of 100% and a specificity of 83.3% for predicting the occurrence of RV dysfunction after pericardiocentesis (AUC = 0.910).
Conclusions—The occurrence of RV dysfunction after pericardiocentesis should be given more attention. Pre-existing RV dysfunction maybe related to the occurrence of RV dysfunction after pericardiocentesis.
Changes in RV function before and after Before Immediately after One day after P−value Basal right ventricular linear dimension (mm) 32.8 ± 5.0 37.1 ± 4.4† 33.6 ± 5.4 0.028 Mid-cavity right ventricular linear dimension (mm) 34.5 ± 4.6 38.8 ± 5.3† 37.0 ± 5.6 0.0504 Proximal right ventricular outflow diameter (mm) 30.2 ± 4.0 33.9 ± 3.5† 31.4 ± 3.9 0.014 TAPSE (mm) 20.0 ± 4.2 13.6 ± 4.3* 14.7 ± 3.9 <0.001 S" (cm/s) 12.6 ± 3.3 8.7 ± 2.4* 9.1 ± 2.4 <0.001 Fractional area change (%) 48.3 ± 5.9 37.8 ± 8.0* 40.0 ± 9.0 <0.001 Right ventricular free wall strain (%) −21.3 ± 6.3 −15.8 ± 6.7* −16.9 ± 5.2 0.036 Tricuspid regurgitation velocity peak (m/s) 2.41 ± 0.29 2.43 ± 0.25 2.34 ± 0.32 0.37
Collapse
Affiliation(s)
- H Matsutani
- Tenri Hospital, Department of Clinical Laboratory, Tenri, Japan
| | - M Amano
- National Cerebral and Cardiovascular Center, Department of Cardiovascular Medicine, Osaka, Japan
| | - C Izumi
- National Cerebral and Cardiovascular Center, Department of Cardiovascular Medicine, Osaka, Japan
| | - M Baba
- Tenri Hospital, Department of Clinical Laboratory, Tenri, Japan
| | - R Abe
- Tenri Hospital, Department of Clinical Laboratory, Tenri, Japan
| | - S Hashiwada
- Tenri Hospital, Department of Clinical Laboratory, Tenri, Japan
| | - K Kuwano
- Tenri Hospital, Department of Clinical Laboratory, Tenri, Japan
| | - M Shimada
- Tenri Hospital, Department of Clinical Laboratory, Tenri, Japan
| | - J Sakamoto
- Tenri Hospital, Department of Cardiology, Tenri, Japan
| | - M Miyake
- Tenri Hospital, Department of Cardiology, Tenri, Japan
| | - T Tamura
- Tenri Hospital, Department of Cardiology, Tenri, Japan
| | - S Matsuo
- Tenri Hospital, Department of Clinical Laboratory, Tenri, Japan
| |
Collapse
|
41
|
Himi K, Takeichi O, Imai K, Hatori K, Tamura T, Ogiso B. Epstein-Barr virus reactivation by persistent apical periodontal pathogens. Int Endod J 2019; 53:492-505. [PMID: 31730263 DOI: 10.1111/iej.13255] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2019] [Accepted: 11/13/2019] [Indexed: 12/12/2022]
Abstract
AIM To assess whether Epstein-Barr virus (EBV) reactivation is triggered by persistent apical periodontitis-related microbes using in vitro and ex vivo methodologies. METHODOLOGY Surgically removed human periapical granulomas (n = 50) and healthy gingival tissues (n = 10) were analysed to determine the presence of EBV and seven persistent apical periodontitis-related microbes. In addition, real-time polymerase chain reaction was used to detect the mRNA expression of BZLF-1, an immediate-early gene of EBV. Expression of latent membrane protein (LMP)-1 and ZEBRA, an early lytic protein of EBV encoded by BZLF-1, was also examined using triple-colour immunofluorescence staining. n-Butyric acid produced by the microbes was quantified, and luciferase assays were performed in association with bacterial lysates. In addition, Daudi cells were cultured with bacterial lysates, and the expression levels of BZLF-1 mRNA and ZEBRA protein were determined. RESULTS EBV DNA and BZLF-1 mRNA were detected in 47 out of 50 periapical granulomas, but not in healthy gingival tissues. The EBV DNA copy number and the number of Fusobacterium nucleatum were significantly positively correlated with BZLF-1 expression in periapical granulomas. The number of Prevotella intermedia was slightly correlated with BZLF-1 expression; however, the other microbes were not. CD79a-positive B cells in periapical granulomas, but not those in healthy gingival tissues, expressed both LMP-1 and ZEBRA. n-Butyric acid production was the highest in F. nucleatum and the lowest in P. intermedia. Enterococcus faecalis, Candida albicans and the other tested microbes did not produce n-butyric acid. An F. nucleatum lysate exhibited significantly increased BZLF-1-luciferase activity in the same manner of commercial butyric acid, whereas P. intermedia did not. F. nucleatum also induced the expression of BZLF-1 mRNA and ZEBRA protein by Daudi cells, indicating that EBV reactivation was induced. CONCLUSION Among the persistent apical periodontitis-related bacteria that were tested, F. nucleatum most strongly reactivated latent EBV, whereas E. faecalis and C. albicans as well as the other microbes did not.
Collapse
Affiliation(s)
- K Himi
- Department of Endodontics, School of Dentistry, Nihon University, Tokyo, Japan
| | - O Takeichi
- Department of Endodontics, School of Dentistry, Nihon University, Tokyo, Japan.,Division of Advanced Dental Treatment, Dental Research Centre, School of Dentistry, Nihon University, Tokyo, Japan
| | - K Imai
- Department of Microbiology, School of Dentistry, Nihon University, Tokyo, Japan.,Division of Immunology and Pathobiology, Dental Research Centre, School of Dentistry, Nihon University, Tokyo, Japan
| | - K Hatori
- Department of Endodontics, School of Dentistry, Nihon University, Tokyo, Japan.,Division of Advanced Dental Treatment, Dental Research Centre, School of Dentistry, Nihon University, Tokyo, Japan
| | - T Tamura
- Department of Endodontics, School of Dentistry, Nihon University, Tokyo, Japan
| | - B Ogiso
- Department of Endodontics, School of Dentistry, Nihon University, Tokyo, Japan.,Division of Advanced Dental Treatment, Dental Research Centre, School of Dentistry, Nihon University, Tokyo, Japan
| |
Collapse
|
42
|
Moriwaki T, Fukuoka S, Masuishi T, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama A, Denda T, Hatachi Y, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Oki E, Komatsu Y, Tsuji A, Tsuchihashi K, Sakai D, Ueno H, Tamura T, Yamashita K, Shimada Y. Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study. Int J Clin Oncol 2019; 25:614-621. [PMID: 31838590 DOI: 10.1007/s10147-019-01600-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2019] [Accepted: 12/07/2019] [Indexed: 02/07/2023]
Abstract
BACKGROUND Although regorafenib or trifluridine/tipiracil (FTD/TPI) has been recognized as a later-line standard treatment in patients with metastatic colorectal cancer (mCRC), not all patients have beneficial outcomes. This study aimed to develop a prognostic scoring system for evaluating the overall survival (OS) benefit. METHODS Patients included in the REGOTAS study, which comprised 489 patients (regorafenib group: 199; FTD/TPI group: 290 patients), were evaluated. OS was analyzed using multivariate Cox proportional model. The prognostic score was calculated using the worst four individual factors weighted by hazard ratio, and the total scores were categorized as low-, moderate-, and high-OS benefit. RESULTS The worst four factors in the regorafenib group were AST > 40 IU/dL (point, + 3), CRP ≥ 1.0 mg/dL (+ 2), number of metastatic organ site ≥ 3 (+ 2), and duration from initiation of 1st-line chemotherapy < 18 months (+ 2), while they were AST (+ 2), CRP (+ 2), CA19-9 > 37.0 U/mL (+ 2), and ECOG PS ≥ 1 (+ 2) in the FTD/TPI group. These corresponded to a total prognostic score of > 5, 2-4, and 0 points in the regorafenib group and 8, 2-6, and 0 points in the FTD/TPI group. The median OS in the low, moderate, and high OS benefit group was 3.3 (95% CI 3.0-3.7), 8.1 (95% CI 6.4-9.7), and 12.6 months (95% CI 10.6-14.6) in the regorafenib group and 2.8 (95% CI 2.0-3.5), 7.5 (95% CI 6.6-8.3), and 15.4 months (95% CI 9.7-21.2) in the FTD/TPI group. CONCLUSION These prognostic scores are useful for identifying patients with mCRC who will obtain survival benefits from these drugs.
Collapse
Affiliation(s)
- Toshikazu Moriwaki
- Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki, 305-8575, Japan.
| | - Shota Fukuoka
- Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan
| | - Toshiki Masuishi
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan
| | - Atsuo Takashima
- Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
| | - Yosuke Kumekawa
- Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan
| | - Takeshi Kajiwara
- Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan
| | - Kentaro Yamazaki
- Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
| | - Taito Esaki
- Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
| | - Akitaka Makiyama
- Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan
| | - Tadamichi Denda
- Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan
| | - Yukimasa Hatachi
- Department of Medical Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan
| | - Takeshi Suto
- Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan
| | - Naotoshi Sugimoto
- Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Masanobu Enomoto
- Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan
| | - Toshiaki Ishikawa
- Department of Specialized Surgeries, Tokyo Medical and Dental University, Graduate School of Medicine and Dentistry, Tokyo, Japan
| | - Tomomi Kashiwada
- Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan
| | - Eiji Oki
- Department Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Yoshito Komatsu
- Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Hokkaido, Japan
| | - Akihito Tsuji
- Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan
| | - Kenji Tsuchihashi
- Department of Medicine and Biosystemic Science, Kyushu University Graduate of Medical Sciences, Fukuoka, Japan
| | - Daisuke Sakai
- Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Hideki Ueno
- Department of Surgery, National Defense Medical College Hospital, Saitama, Japan
| | - Takao Tamura
- Department of Medical Oncology, Kindai University, Faculty of Medicine, Osaka, Japan
| | - Kimihiro Yamashita
- Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Hyogo, Japan
| | - Yasuhiro Shimada
- Clinical Oncology Division, Kochi Health Sciences Center, Kochi, Japan
| |
Collapse
|
43
|
Tamura T, Yokota S, Ando M, Kubo Y, Nishiwaki K. A triple-blinded randomized trial comparing spinal morphine with posterior quadratus lumborum block after cesarean section. Int J Obstet Anesth 2019; 40:32-38. [DOI: 10.1016/j.ijoa.2019.06.008] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/24/2019] [Revised: 05/16/2019] [Accepted: 06/16/2019] [Indexed: 10/26/2022]
|
44
|
Tamaki Y, Yaku H, Yamamoto E, Ozasa N, Inuzuka Y, Kondo H, Tamura T, Morimoto T, Nakagawa Y, Kimura T, Kato T. P4544Impact of hyponatremia improvement on one-year outcomes in patients with acute decompensated heart failure. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Impact of hyponatremia improvement on prognosis in patients with acute decompensated heart failure (ADHF) remains unclear.
Methods
Patients hospitalized for ADHF at 19 hospitals in Japan were enrolled between October 2014 and March 2016. Hyponatremia was defined as serum sodium concentration less than 135 mmol/l. Primary endpoint was composite of all-cause death and heart failure rehospitalization one year after discharge.
Results
Among 3805 patients enrolled, 486 patients with hyponatremia at admission showed higher in-hospital mortality (13.3% vs. 5.4%, p<0.001). Of 486 hyponatremic patients, 396 patients were discharged alive. One hundred forty-three patients showed persistent hyponatremia at discharge (group P), whereas 253 patients showed improvement of hyponatremia (group I). Baseline characteristics are shown in the table. Patients in group I showed higher sodium concentration at admission (132±3 mmol/l vs. 130±4 mmol/l, p<0.001) and more increase in serum sodium concentration at discharge (7±4 mmol/l vs. 1±5 mmol/l, p<0.001). One-year survival rate free from primary endpoint was not different between the groups (56.4% in group P vs. 58.5% in group I, p=0.79). After adjusting for confounders, improvement of hyponatremia was not associated with better prognosis (hazard ratio 1.00; 95% confidence interval 0.70–1.45, p=0.99). Hyponatremia improvement showed significant interaction with left ventricular ejection fraction (LVEF) less than 40% (p=0.01). In patients with LVEF<40%, improvement of hyponatremia was associated with better prognosis (hazard ratio 0.48, 95% confidence interval 0.28–0.85, p=0.01) whereas not in patients LVEF≥40%.
Patient characteristics Group P (n=143) Group I (n=253) p value Age (years) 81 (72–86) 81 (72–87) 0.73 Female 71 (49.7) 110 (43.5) 0.24 Ischemic etiology 42 (29.4) 81 (32.0) 0.58 Prior hospitalization 62 (43.7) 98 (39.5) 0.42 SBP at admission (mmHg) 140±36 144±38 0.40 HR at admission (bpm) 92±23 95±29 0.27 Atrial Fibrillation 47 (32.9) 103 (40.7) 0.12 NYHA class IV 60 (42.2) 138 (54.8) 0.02 Intravenous inotropic use 35 (24.5) 59 (23.3) 0.80 LVEF <40% 54 (37.8) 95 (37.6) 0.97 Values are median (interquartile range), mean ± standard deviation or number (%).
Conclusion
Improvement of hyponatremia at discharge was not associated with better prognosis in patients hospitalized for ADHF.
Collapse
Affiliation(s)
- Y Tamaki
- Tenri Hospital, Department of Cardiology, Tenri, Japan
| | - H Yaku
- Kyoto University Graduate School of Medicine, Department of Cardiovascular Medicine, Kyoto, Japan
| | - E Yamamoto
- Kyoto University Graduate School of Medicine, Department of Cardiovascular Medicine, Kyoto, Japan
| | - N Ozasa
- Kyoto University Graduate School of Medicine, Department of Cardiovascular Medicine, Kyoto, Japan
| | - Y Inuzuka
- Shiga General Hospital, Department of Cardiology, Moriyama, Japan
| | - H Kondo
- Tenri Hospital, Department of Cardiology, Tenri, Japan
| | - T Tamura
- Tenri Hospital, Department of Cardiology, Tenri, Japan
| | - T Morimoto
- Hyogo College of Medicine, Department of Clinical Epidemiology, Nishinomiya, Japan
| | - Y Nakagawa
- Shiga University of Medical Science, Department of Cardiovascular Medicine, Otsu, Japan
| | - T Kimura
- Kyoto University Graduate School of Medicine, Department of Cardiovascular Medicine, Kyoto, Japan
| | - T Kato
- Kyoto University Graduate School of Medicine, Department of Cardiovascular Medicine, Kyoto, Japan
| |
Collapse
|
45
|
Sekine, Harada H, Yamamoto N, Wakabayashi M, Murakami H, Goto K, Nogami N, Seto T, Oshita F, Okamoto H, Tanaka H, Tamura T, Ishikura S, Ohe Y. Randomized phase II trial of CODE or AP after chemoradiotherapy for LD-SCLC: Long-term survival and toxicity analysis. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz264.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
46
|
Nakamura M, Sunakawa Y, Okuyama H, Matsuura M, Negoro Y, Yabuno T, Takahashi T, Tamura T, Takeuchi N, Satake H, Miyamoto Y, Kataoka M, Shiozawa M, Makiyama A, Kobayashi K, Kubota Y, Sekikawa T, Takeuchi M, Ichikawa W, Fujii M. Update on JACCRO CC-11 trial of 1st-line modified-FOLFOXIRI plus bevacizumab for RAS mutant metastatic colorectal cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz338.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Ototake Y, Yamaguchi Y, Asami M, Komitsu N, Watanabe T, Kurotaki D, Tamura T, Aihara M. 024 Downregulated expression of Interferon regulatory factor 8 in monocytes/macrophages exhibits pro-fibrotic phenotype and may contribute to the pathogenic process of systemic sclerosis. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
48
|
Tsujie M, Fumita S, Ishikawa H, Kitani K, Satoi S, Fukuda S, Manabe H, Akashi Y, Wakasa T, Shiono H, Tamura T, Yukawa M, Inoue M. [Outcomes of FOLFIRINOX as First-Line Treatment for Recurrent or Unresectable Pancreatic Cancer]. Gan To Kagaku Ryoho 2019; 46:1259-1263. [PMID: 31501367] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
We retrospectively analyzed adverse effects(AEs), overall survival(OS), and progression-free survival(PFS)in 15 consecutive patients treated with FOLFIRINOX as the first-line treatment for recurrent or unresectable pancreatic ductal adenocarcinoma( PDAC)between February 2014 and December 2017 in our hospital. Eleven patients were treated for unresectable PDAC with distant metastases(UR-M), and 4 were treated for locally advanced unresectable PDAC(UR-LA). The median age was 56(range: 40-75)years. Nine patients were male, and 6 were female. The performance status was 0 or 1 in all patients. Tumors were located in the pancreas head in 8 cases and in the body-tail in 7 cases. Grade 5 AEs were observed in 1 case in which liver abscess causing sepsis resulted in mortality. The response rate was 20.0%, and the disease control rate was 66.7%. Two patients underwent conversion surgery after FOLFIRINOX treatment. Seven patients received a nab-paclitaxel plus gemcitabine regimen as second-line treatment. The median OS and PFS were 17.0 and 8.4 months, respectively, and the 1-year survival rate was 66.7%. FOLFIRINOX for recurrent and unresectable PDAC showed relatively good tumor control. However, strict attention is required for severe AEs. Conversion surgery might be effective in patients who are good responders even if they have metastatic disease.
Collapse
|
49
|
Yamada Y, Boku N, Mizusawa J, Iwasa S, Kadowaki S, Nakayama N, Azuma M, Sakamoto T, Shitara K, Tamura T, Chin K, Hata H, Nakamori M, Hara H, Yasui H, Katayama H, Fukuda H, Yoshikawa T, Sasako M, Terashima M. Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol 2019; 4:501-510. [PMID: 31101534 DOI: 10.1016/s2468-1253(19)30083-4] [Citation(s) in RCA: 79] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/30/2019] [Revised: 02/25/2019] [Accepted: 02/25/2019] [Indexed: 12/27/2022]
Abstract
BACKGROUND We investigated the superiority of docetaxel plus cisplatin and S-1 compared with cisplatin and S-1 in chemotherapy-naive patients with advanced gastric cancer. METHODS In this open-label, phase 3, randomised controlled trial, patients were recruited from 56 hospitals in Japan. We enrolled individuals aged 20-75 years who had unresectable or recurrent gastric cancer, had an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, had received no previous chemotherapy (except adjuvant chemotherapy completed 24 weeks before reccurence), radiotherapy, or hormonal therapy, could take drugs orally, and had adequate organ function. Patients were randomly assigned (1:1) to receive docetaxel plus cisplatin and S-1 (docetaxel 40 mg/m2 and cisplatin 60 mg/m2 on day 1 intravenously, and S-1 40-60 mg twice a day orally for 2 weeks, every 4 weeks) or cisplatin and S-1 (cisplatin 60 mg/m2 intravenously on day 8, and S-1 40-60 mg orally twice a day for 3 weeks, every 5 weeks). Randomisation was done centrally with the minimisation method, with a random component balancing for institution, ECOG performance status (0 vs 1), disease status at enrolment (unresectable vs recurrent), measurable lesion (yes vs no), number of metastatic sites (0-1 vs ≥2), and histological type (differentiated vs undifferentiated). Neither investigators or patients were masked to the study treatment. The primary endpoint was overall survival in the intention-to-treat population. The study is registered with UMIN-CTR, number UMIN000007652. FINDINGS Between April 3, 2012, and March 18, 2016, 741 patients were randomly assigned to receive docetaxel plus cisplatin and S-1 (n=370) or cisplatin and S-1 (n=371). Median overall survival was 14·2 months (95% CI 12·9-15·9) in the docetaxel plus cisplatin and S-1 group and 15·3 months (14·2-16·2) in the cisplatin and S-1 group (hazard ratio [HR] 0·99 [95% CI 0·85-1·16]; one-sided stratified log-rank p=0·47). The most common grade 3 or worse adverse events were neutropenia (209 [59%] of 357 patients in the docetaxel plus cisplatin and S-1 group vs 117 [32%] of 365 patients in the cisplatin and S-1 group), leukopenia (120 [34%] vs 60 [16%]), and anorexia (94 [26%] vs 81 [22%]). The deaths of one patient in the cisplatin and S-1 group and in three patients in the docetaxel plus cisplatin and S-1 group were deemed treatment-related. INTERPRETATION The addition of docetaxel to cisplatin and S-1 did not improve overall survival in chemotherapy-naive Japanese patients with advanced gastric cancer. Therefore, cisplatin and S-1 remains the standard first-line chemotherapy. FUNDING Ministry of Health, Labour and Welfare and Japan Agency for Medical Research and Development.
Collapse
Affiliation(s)
- Yasuhide Yamada
- Comprehensive Cancer Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan; Department of Medical Oncology, Hamamatsu University School of Medicine, Shizuoka, Japan; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
| | - Narikazu Boku
- Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
| | - Junki Mizusawa
- Japan Clinical Oncology Group Data Center and Operations Office, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
| | - Satoru Iwasa
- Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
| | - Shigenori Kadowaki
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Aichi, Japan
| | - Norisuke Nakayama
- Department of Gastroenterology, Kanagawa Cancer Center Hospital, Asahi-ku, Yokohama, Kanagawa, Japan
| | - Mizutomo Azuma
- Department of Gastroenterology, Kitasato University School of Medicine, Minami, Sagamihara, Kanagawa, Japan
| | - Takeshi Sakamoto
- Department of Gastroenterology, Hyogo Cancer Center, Akashi, Hyogo, Japan
| | - Kohei Shitara
- Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
| | - Takao Tamura
- Department of Medical Oncology, Kindai University, Faculty of Medicine, Osaka, Japan
| | - Keisho Chin
- Department of Gastroenterology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan
| | - Hiroaki Hata
- Department of Surgery, National Hospital Organization Kyoto Medical Center, Fushimi-ku, Kyoto, Japan
| | - Mikihito Nakamori
- Second Department of Surgery, School of Medicine, Wakayama Medical University, Wakayama, Japan
| | - Hiroki Hara
- Department of Gastroenterology, Saitama Cancer Center, Inamachi, Kitaadachi-gun, Saitama, Japan
| | - Hirofumi Yasui
- Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan
| | - Hiroshi Katayama
- Japan Clinical Oncology Group Data Center and Operations Office, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
| | - Haruhiko Fukuda
- Japan Clinical Oncology Group Data Center and Operations Office, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
| | - Takaki Yoshikawa
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center Hospital, Asahi-ku, Yokohama, Kanagawa, Japan
| | - Mitsuru Sasako
- Department of Surgery, Hyogo College of Medicine, Fushimi-ku Mukogawa-cho, Nishinomiya-shi, Hyogo, Japan
| | - Masanori Terashima
- Division of Gastric Surgery, Shizuoka Cancer Center, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan
| |
Collapse
|
50
|
Adriani O, Akaike Y, Asano K, Asaoka Y, Bagliesi MG, Berti E, Bigongiari G, Binns WR, Bonechi S, Bongi M, Brogi P, Bruno A, Buckley JH, Cannady N, Castellini G, Checchia C, Cherry ML, Collazuol G, Di Felice V, Ebisawa K, Fuke H, Guzik TG, Hams T, Hasebe N, Hibino K, Ichimura M, Ioka K, Ishizaki W, Israel MH, Kasahara K, Kataoka J, Kataoka R, Katayose Y, Kato C, Kawanaka N, Kawakubo Y, Kohri K, Krawczynski HS, Krizmanic JF, Lomtadze T, Maestro P, Marrocchesi PS, Messineo AM, Mitchell JW, Miyake S, Moiseev AA, Mori K, Mori M, Mori N, Motz HM, Munakata K, Murakami H, Nakahira S, Nishimura J, de Nolfo GA, Okuno S, Ormes JF, Ozawa S, Pacini L, Palma F, Papini P, Penacchioni AV, Rauch BF, Ricciarini SB, Sakai K, Sakamoto T, Sasaki M, Shimizu Y, Shiomi A, Sparvoli R, Spillantini P, Stolzi F, Suh JE, Sulaj A, Takahashi I, Takayanagi M, Takita M, Tamura T, Terasawa T, Tomida H, Torii S, Tsunesada Y, Uchihori Y, Ueno S, Vannuccini E, Wefel JP, Yamaoka K, Yanagita S, Yoshida A, Yoshida K. Direct Measurement of the Cosmic-Ray Proton Spectrum from 50 GeV to 10 TeV with the Calorimetric Electron Telescope on the International Space Station. Phys Rev Lett 2019; 122:181102. [PMID: 31144869 DOI: 10.1103/physrevlett.122.181102] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/28/2018] [Revised: 03/03/2019] [Indexed: 06/09/2023]
Abstract
In this paper, we present the analysis and results of a direct measurement of the cosmic-ray proton spectrum with the CALET instrument onboard the International Space Station, including the detailed assessment of systematic uncertainties. The observation period used in this analysis is from October 13, 2015 to August 31, 2018 (1054 days). We have achieved the very wide energy range necessary to carry out measurements of the spectrum from 50 GeV to 10 TeV covering, for the first time in space, with a single instrument the whole energy interval previously investigated in most cases in separate subranges by magnetic spectrometers (BESS-TeV, PAMELA, and AMS-02) and calorimetric instruments (ATIC, CREAM, and NUCLEON). The observed spectrum is consistent with AMS-02 but extends to nearly an order of magnitude higher energy, showing a very smooth transition of the power-law spectral index from -2.81±0.03 (50-500 GeV) neglecting solar modulation effects (or -2.87±0.06 including solar modulation effects in the lower energy region) to -2.56±0.04 (1-10 TeV), thereby confirming the existence of spectral hardening and providing evidence of a deviation from a single power law by more than 3σ.
Collapse
Affiliation(s)
- O Adriani
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - Y Akaike
- Department of Physics, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - K Asano
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - Y Asaoka
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
- JEM Utilization Center, Human Spaceflight Technology Directorate, Japan Aerospace Exploration Agency, 2-1-1 Sengen, Tsukuba, Ibaraki 305-8505, Japan
| | - M G Bagliesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - E Berti
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - G Bigongiari
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - W R Binns
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S Bonechi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - M Bongi
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - P Brogi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Bruno
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - J H Buckley
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - N Cannady
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Castellini
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - C Checchia
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - M L Cherry
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - G Collazuol
- Department of Physics and Astronomy, University of Padova, Via Marzolo, 8, 35131 Padova, Italy
- INFN Sezione di Padova, Via Marzolo, 8, 35131 Padova, Italy
| | - V Di Felice
- University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
- INFN Sezione di Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - K Ebisawa
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - H Fuke
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - T G Guzik
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - T Hams
- Department of Physics, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- CRESST and Astroparticle Physics Laboratory NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - N Hasebe
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Hibino
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - M Ichimura
- Faculty of Science and Technology, Graduate School of Science and Technology, Hirosaki University, 3, Bunkyo, Hirosaki, Aomori 036-8561, Japan
| | - K Ioka
- Yukawa Institute for Theoretical Physics, Kyoto University, Kitashirakawa Oiwakecho, Sakyo, Kyoto 606-8502, Japan
| | - W Ishizaki
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - M H Israel
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - K Kasahara
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - J Kataoka
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - R Kataoka
- National Institute of Polar Research, 10-3, Midori-cho, Tachikawa, Tokyo 190-8518, Japan
| | - Y Katayose
- Faculty of Engineering, Division of Intelligent Systems Engineering, Yokohama National University, 79-5 Tokiwadai, Hodogaya, Yokohama 240-8501, Japan
| | - C Kato
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - N Kawanaka
- Hakubi Center, Kyoto University, Yoshida Honmachi, Sakyo-ku, Kyoto 606-8501, Japan
- Department of Astronomy, Graduate School of Science, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
| | - Y Kawakubo
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Kohri
- Institute of Particle and Nuclear Studies, High Energy Accelerator Research Organization, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan
| | - H S Krawczynski
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - J F Krizmanic
- Department of Physics, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- CRESST and Astroparticle Physics Laboratory NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Lomtadze
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - P Maestro
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - P S Marrocchesi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A M Messineo
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
- University of Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - J W Mitchell
- Astroparticle Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Miyake
- Department of Electrical and Electronic Systems Engineering, National Institute of Technology, Ibaraki College, 866 Nakane, Hitachinaka, Ibaraki 312-8508 Japan
| | - A A Moiseev
- CRESST and Astroparticle Physics Laboratory NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - K Mori
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - M Mori
- Department of Physical Sciences, College of Science and Engineering, Ritsumeikan University, Shiga 525-8577, Japan
| | - N Mori
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - H M Motz
- Faculty of Science and Engineering, Global Center for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - K Munakata
- Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan
| | - H Murakami
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - S Nakahira
- RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - J Nishimura
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - G A de Nolfo
- Heliospheric Physics Laboratory, NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - S Okuno
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - J F Ormes
- Department of Physics and Astronomy, University of Denver, Physics Building, Room 211, 2112 East Wesley Avenue, Denver, Colorado 80208-6900, USA
| | - S Ozawa
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - L Pacini
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - F Palma
- University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
- INFN Sezione di Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - P Papini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - A V Penacchioni
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- ASI Science Data Center (ASDC), Via del Politecnico snc, 00133 Rome, Italy
| | - B F Rauch
- Department of Physics and McDonnell Center for the Space Sciences, Washington University, One Brookings Drive, St. Louis, Missouri 63130-4899, USA
| | - S B Ricciarini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
- Institute of Applied Physics (IFAC), National Research Council (CNR), Via Madonna del Piano, 10, 50019 Sesto, Fiorentino, Italy
| | - K Sakai
- Department of Physics, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, Maryland 21250, USA
- CRESST and Astroparticle Physics Laboratory NASA/GSFC, Greenbelt, Maryland 20771, USA
| | - T Sakamoto
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - M Sasaki
- CRESST and Astroparticle Physics Laboratory NASA/GSFC, Greenbelt, Maryland 20771, USA
- Department of Astronomy, University of Maryland, College Park, Maryland 20742, USA
| | - Y Shimizu
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - A Shiomi
- College of Industrial Technology, Nihon University, 1-2-1 Izumi, Narashino, Chiba 275-8575, Japan
| | - R Sparvoli
- University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
- INFN Sezione di Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133 Rome, Italy
| | - P Spillantini
- Department of Physics, University of Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - F Stolzi
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - J E Suh
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - A Sulaj
- Department of Physical Sciences, Earth and Environment, University of Siena, via Roma 56, 53100 Siena, Italy
- INFN Sezione di Pisa, Polo Fibonacci, Largo B. Pontecorvo, 3-56127 Pisa, Italy
| | - I Takahashi
- Kavli Institute for the Physics and Mathematics of the Universe, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, 277-8583, Japan
| | - M Takayanagi
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - M Takita
- Institute for Cosmic Ray Research, The University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa, Chiba 277-8582, Japan
| | - T Tamura
- Kanagawa University, 3-27-1 Rokkakubashi, Kanagawa, Yokohama, Kanagawa 221-8686, Japan
| | - T Terasawa
- RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - H Tomida
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - S Torii
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
- School of Advanced Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan
| | - Y Tsunesada
- Division of Mathematics and Physics, Graduate School of Science, Osaka City University, 3-3-138 Sugimoto, Sumiyoshi, Osaka 558-8585, Japan
| | - Y Uchihori
- National Institutes for Quantum and Radiation Science and Technology, 4-9-1 Anagawa, Inage, Chiba 263-8555, Japan
| | - S Ueno
- Institute of Space and Astronautical Science, Japan Aerospace Exploration Agency, 3-1-1 Yoshinodai, Chuo, Sagamihara, Kanagawa 252-5210, Japan
| | - E Vannuccini
- INFN Sezione di Florence, Via Sansone, 1-50019 Sesto, Fiorentino, Italy
| | - J P Wefel
- Department of Physics and Astronomy, Louisiana State University, 202 Nicholson Hall, Baton Rouge, Louisiana 70803, USA
| | - K Yamaoka
- Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan
| | - S Yanagita
- College of Science, Ibaraki University, 2-1-1 Bunkyo, Mito, Ibaraki 310-8512, Japan
| | - A Yoshida
- College of Science and Engineering, Department of Physics and Mathematics, Aoyama Gakuin University, 5-10-1 Fuchinobe, Chuo, Sagamihara, Kanagawa 252-5258, Japan
| | - K Yoshida
- Department of Electronic Information Systems, Shibaura Institute of Technology, 307 Fukasaku, Minuma, Saitama 337-8570, Japan
| |
Collapse
|